Exact Mass: 404.3012

Exact Mass Matches: 404.3012

Found 500 metabolites which its exact mass value is equals to given mass value 404.3012, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Lovastatin

[(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] (2S)-2-methylbutanoate

C24H36O5 (404.2563)


Lovastatin is a fatty acid ester that is mevastatin carrying an additional methyl group on the carbobicyclic skeleton. It is used in as an anticholesteremic drug and has been found in fungal species such as Aspergillus terreus and Pleurotus ostreatus (oyster mushroom). It has a role as an Aspergillus metabolite, a prodrug, an anticholesteremic drug and an antineoplastic agent. It is a polyketide, a statin (naturally occurring), a member of hexahydronaphthalenes, a delta-lactone and a fatty acid ester. It is functionally related to a (S)-2-methylbutyric acid and a mevastatin. Lovastatin, also known as the brand name product Mevacor, is a lipid-lowering drug and fungal metabolite derived synthetically from a fermentation product of Aspergillus terreus. Originally named Mevinolin, lovastatin belongs to the statin class of medications, which are used to lower the risk of cardiovascular disease and manage abnormal lipid levels by inhibiting the endogenous production of cholesterol in the liver. More specifically, statin medications competitively inhibit the enzyme hydroxymethylglutaryl-coenzyme A (HMG-CoA) Reductase, which catalyzes the conversion of HMG-CoA to mevalonic acid and is the third step in a sequence of metabolic reactions involved in the production of several compounds involved in lipid metabolism and transport including cholesterol, low-density lipoprotein (LDL) (sometimes referred to as "bad cholesterol"), and very low-density lipoprotein (VLDL). Prescribing of statin medications is considered standard practice following any cardiovascular events and for people with a moderate to high risk of development of CVD, such as those with Type 2 Diabetes. The clear evidence of the benefit of statin use coupled with very minimal side effects or long term effects has resulted in this class becoming one of the most widely prescribed medications in North America. Lovastatin and other drugs from the statin class of medications including [atorvastatin], [pravastatin], [rosuvastatin], [fluvastatin], and [simvastatin] are considered first-line options for the treatment of dyslipidemia. Increasing use of the statin class of drugs is largely due to the fact that cardiovascular disease (CVD), which includes heart attack, atherosclerosis, angina, peripheral artery disease, and stroke, has become a leading cause of death in high-income countries and a major cause of morbidity around the world. Elevated cholesterol levels, and in particular, elevated low-density lipoprotein (LDL) levels, are an important risk factor for the development of CVD. Use of statins to target and reduce LDL levels has been shown in a number of landmark studies to significantly reduce the risk of development of CVD and all-cause mortality. Statins are considered a cost-effective treatment option for CVD due to their evidence of reducing all-cause mortality including fatal and non-fatal CVD as well as the need for surgical revascularization or angioplasty following a heart attack. Evidence has shown that even for low-risk individuals (with <10\\\\% risk of a major vascular event occurring within 5 years) statins cause a 20\\\\%-22\\\\% relative reduction in major cardiovascular events (heart attack, stroke, coronary revascularization, and coronary death) for every 1 mmol/L reduction in LDL without any significant side effects or risks. While all statin medications are considered equally effective from a clinical standpoint, [rosuvastatin] is considered the most potent; doses of 10 to 40mg [rosuvastatin] per day were found in clinical studies to result in a 45.8\\\\% to 54.6\\\\% decrease in LDL cholesterol levels, while lovastatin has been found to have an average decrease in LDL-C of 25-40\\\\%. Potency is thought to correlate to tissue permeability as the more lipophilic statins such as lovastatin are thought to enter endothelial cells by passive diffusion, as opposed to hydrophilic statins such as [pravastatin] and [rosuvastatin] which are taken up into hepatocytes through OATP1B1 (org... Lovastatin is a cholesterol-lowering agent that belongs to the class of medications called statins. It was the second agent of this class discovered. It was discovered by Alfred Alberts and his team at Merck in 1978 after screening only 18 compounds over 2 weeks. The agent, also known as mevinolin, was isolated from the fungi Aspergillus terreus. Research on this compound was suddenly shut down in 1980 and the drug was not approved until 1987. Interesting, Akira Endo at Sankyo Co. (Japan) patented lovastatin isolated from Monascus ruber four months before Merck. Lovastatin was found to be 2 times more potent than its predecessor, mevastatin, the first discovered statin. Like mevastatin, lovastatin is structurally similar to hydroxymethylglutarate (HMG), a substituent of HMG-Coenzyme A (HMG-CoA), a substrate of the cholesterol biosynthesis pathway via the mevalonic acid pathway. Lovastatin is a competitive inhibitor of HMG-CoA reductase with a binding affinity 20,000 times greater than HMG-CoA. Lovastatin differs structurally from mevastatin by a single methyl group at the 6 position. Lovastatin is a prodrug that is activated by in vivo hydrolysis of the lactone ring. It, along with mevastatin, has served as one of the lead compounds for the development of the synthetic compounds used today. A fatty acid ester that is mevastatin carrying an additional methyl group on the carbobicyclic skeleton. It is used in as an anticholesteremic drug and has been found in fungal species such as Aspergillus terreus and Pleurotus ostreatus (oyster mushroom). C - Cardiovascular system > C10 - Lipid modifying agents > C10A - Lipid modifying agents, plain > C10AA - Hmg coa reductase inhibitors D057847 - Lipid Regulating Agents > D000960 - Hypolipidemic Agents > D000924 - Anticholesteremic Agents D004791 - Enzyme Inhibitors > D019161 - Hydroxymethylglutaryl-CoA Reductase Inhibitors C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent C471 - Enzyme Inhibitor > C1655 - HMG-CoA Reductase Inhibitor D009676 - Noxae > D000963 - Antimetabolites CONFIDENCE standard compound; EAWAG_UCHEM_ID 3139 CONFIDENCE standard compound; INTERNAL_ID 2212 Lovastatin is a cell-permeable HMG-CoA reductase inhibitor used to lower cholesterol. Lovastatin is a cell-permeable HMG-CoA reductase inhibitor used to lower cholesterol.

   

Androstane-3,17-diol dipropionate

Androstane-3,17-diol dipropionate; 5alpha-Androstane-3alpha,17beta-diol dipropionate

C25H40O4 (404.2926)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones

   

7a,12a-Dihydroxy-3-oxo-4-cholenoic acid

(4R)-4-[(1S,2R,9R,10R,11S,14R,15R,16S)-9,16-dihydroxy-2,15-dimethyl-5-oxotetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-6-en-14-yl]pentanoic acid

C24H36O5 (404.2563)


7a,12a-Dihydroxy-3-oxo-4-cholenoic acid is an unusual bile acids that have been detected in urine early in life, especially during the period up to 1 mo of age. This indicate that bile acid synthesis and metabolism in the liver of developing infants is significantly different from that occurring in the liver of adults. (PMID 10203155) [HMDB] 7a,12a-Dihydroxy-3-oxo-4-cholenoic acid is an unusual bile acids that have been detected in urine early in life, especially during the period up to 1 mo of age. This indicate that bile acid synthesis and metabolism in the liver of developing infants is significantly different from that occurring in the liver of adults. (PMID 10203155).

   

4,4-Diapo-zeta-carotene

4,4-Diapo-zeta-carotene

C30H44 (404.3443)


   

Lucidone C

14-acetyl-5,9,12-trihydroxy-2,6,6,11,15-pentamethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-1(10)-en-17-one

C24H36O5 (404.2563)


Lucidone C is found in mushrooms. Lucidone C is a metabolite of Ganoderma lucidum (reishi). Metabolite of Ganoderma lucidum (reishi). Lucidone C is found in mushrooms.

   

MG(0:0/22:5(4Z,7Z,10Z,13Z,16Z)/0:0)

1,3-Dihydroxypropan-2-yl (4Z,10Z,13Z,16Z)-docosa-4,7,10,13,16-pentaenoic acid

C25H40O4 (404.2926)


MG(0:0/22:5(4Z,7Z,10Z,13Z,16Z)/0:0) is a monoacylglyceride. A monoglyceride, more correctly known as a monoacylglycerol, is a glyceride consisting of one fatty acid chain covalently bonded to a glycerol molecule through an ester linkage. Monoacylglycerol can be broadly divided into two groups; 1-monoacylglycerols (or 3-monoacylglycerols) and 2-monoacylglycerols, depending on the position of the ester bond on the glycerol moiety. Normally the 1-/3-isomers are not distinguished from each other and are termed alpha-monoacylglycerols, while the 2-isomers are beta-monoacylglycerols. Monoacylglycerols are formed biochemically via release of a fatty acid from diacylglycerol by diacylglycerol lipase or hormone sensitive lipase. Monoacylglycerols are broken down by monoacylglycerol lipase. They tend to be minor components only of most plant and animal tissues, and indeed would not be expected to accumulate because their strong detergent properties would have a disruptive effect on membranes. 2-Monoacylglycerols are a major end product of the intestinal digestion of dietary fats in animals via the enzyme pancreatic lipase. They are taken up directly by the intestinal cells and converted to triacylglycerols via the monoacylglycerol pathway before being transported in lymph to the liver. Mono- and Diglycerides are commonly added to commercial food products in small quantities. They act as emulsifiers, helping to mix ingredients such as oil and water that would not otherwise blend well.

   

MG(0:0/22:5(7Z,10Z,13Z,16Z,19Z)/0:0)

1,3-dihydroxypropan-2-yl (7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoate

C25H40O4 (404.2926)


MG(0:0/22:5(7Z,10Z,13Z,16Z,19Z)/0:0) is a monoacylglyceride. A monoglyceride, more correctly known as a monoacylglycerol, is a glyceride consisting of one fatty acid chain covalently bonded to a glycerol molecule through an ester linkage. Monoacylglycerol can be broadly divided into two groups; 1-monoacylglycerols (or 3-monoacylglycerols) and 2-monoacylglycerols, depending on the position of the ester bond on the glycerol moiety. Normally the 1-/3-isomers are not distinguished from each other and are termed alpha-monoacylglycerols, while the 2-isomers are beta-monoacylglycerols. Monoacylglycerols are formed biochemically via release of a fatty acid from diacylglycerol by diacylglycerol lipase or hormone sensitive lipase. Monoacylglycerols are broken down by monoacylglycerol lipase. They tend to be minor components only of most plant and animal tissues, and indeed would not be expected to accumulate because their strong detergent properties would have a disruptive effect on membranes. 2-Monoacylglycerols are a major end product of the intestinal digestion of dietary fats in animals via the enzyme pancreatic lipase. They are taken up directly by the intestinal cells and converted to triacylglycerols via the monoacylglycerol pathway before being transported in lymph to the liver. Mono- and Diglycerides are commonly added to commercial food products in small quantities. They act as emulsifiers, helping to mix ingredients such as oil and water that would not otherwise blend well. [HMDB] MG(0:0/22:5(7Z,10Z,13Z,16Z,19Z)/0:0) is a monoacylglyceride. A monoglyceride, more correctly known as a monoacylglycerol, is a glyceride consisting of one fatty acid chain covalently bonded to a glycerol molecule through an ester linkage. Monoacylglycerol can be broadly divided into two groups; 1-monoacylglycerols (or 3-monoacylglycerols) and 2-monoacylglycerols, depending on the position of the ester bond on the glycerol moiety. Normally the 1-/3-isomers are not distinguished from each other and are termed alpha-monoacylglycerols, while the 2-isomers are beta-monoacylglycerols. Monoacylglycerols are formed biochemically via release of a fatty acid from diacylglycerol by diacylglycerol lipase or hormone sensitive lipase. Monoacylglycerols are broken down by monoacylglycerol lipase. They tend to be minor components only of most plant and animal tissues, and indeed would not be expected to accumulate because their strong detergent properties would have a disruptive effect on membranes. 2-Monoacylglycerols are a major end product of the intestinal digestion of dietary fats in animals via the enzyme pancreatic lipase. They are taken up directly by the intestinal cells and converted to triacylglycerols via the monoacylglycerol pathway before being transported in lymph to the liver. Mono- and Diglycerides are commonly added to commercial food products in small quantities. They act as emulsifiers, helping to mix ingredients such as oil and water that would not otherwise blend well.

   

MG(22:5(4Z,7Z,10Z,13Z,16Z)/0:0/0:0)

(2S)-2,3-Dihydroxypropyl (4Z,7Z,10Z,13Z,16Z)-docosa-4,7,10,13,16-pentaenoic acid

C25H40O4 (404.2926)


MG(22:5(4Z,7Z,10Z,13Z,16Z)/0:0/0:0) is a monoacylglyceride. A monoglyceride, more correctly known as a monoacylglycerol, is a glyceride consisting of one fatty acid chain covalently bonded to a glycerol molecule through an ester linkage. Monoacylglycerol can be broadly divided into two groups; 1-monoacylglycerols (or 3-monoacylglycerols) and 2-monoacylglycerols, depending on the position of the ester bond on the glycerol moiety. Normally the 1-/3-isomers are not distinguished from each other and are termed alpha-monoacylglycerols, while the 2-isomers are beta-monoacylglycerols. Monoacylglycerols are formed biochemically via release of a fatty acid from diacylglycerol by diacylglycerol lipase or hormone sensitive lipase. Monoacylglycerols are broken down by monoacylglycerol lipase. They tend to be minor components only of most plant and animal tissues, and indeed would not be expected to accumulate because their strong detergent properties would have a disruptive effect on membranes. 2-Monoacylglycerols are a major end product of the intestinal digestion of dietary fats in animals via the enzyme pancreatic lipase. They are taken up directly by the intestinal cells and converted to triacylglycerols via the monoacylglycerol pathway before being transported in lymph to the liver. Mono- and Diglycerides are commonly added to commercial food products in small quantities. They act as emulsifiers, helping to mix ingredients such as oil and water that would not otherwise blend well. [HMDB] MG(22:5(4Z,7Z,10Z,13Z,16Z)/0:0/0:0) is a monoacylglyceride. A monoglyceride, more correctly known as a monoacylglycerol, is a glyceride consisting of one fatty acid chain covalently bonded to a glycerol molecule through an ester linkage. Monoacylglycerol can be broadly divided into two groups; 1-monoacylglycerols (or 3-monoacylglycerols) and 2-monoacylglycerols, depending on the position of the ester bond on the glycerol moiety. Normally the 1-/3-isomers are not distinguished from each other and are termed alpha-monoacylglycerols, while the 2-isomers are beta-monoacylglycerols. Monoacylglycerols are formed biochemically via release of a fatty acid from diacylglycerol by diacylglycerol lipase or hormone sensitive lipase. Monoacylglycerols are broken down by monoacylglycerol lipase. They tend to be minor components only of most plant and animal tissues, and indeed would not be expected to accumulate because their strong detergent properties would have a disruptive effect on membranes. 2-Monoacylglycerols are a major end product of the intestinal digestion of dietary fats in animals via the enzyme pancreatic lipase. They are taken up directly by the intestinal cells and converted to triacylglycerols via the monoacylglycerol pathway before being transported in lymph to the liver. Mono- and Diglycerides are commonly added to commercial food products in small quantities. They act as emulsifiers, helping to mix ingredients such as oil and water that would not otherwise blend well.

   

MG(22:5(7Z,10Z,13Z,16Z,19Z)/0:0/0:0)

(2S)-2,3-Dihydroxypropyl (7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoic acid

C25H40O4 (404.2926)


MG(22:5(7Z,10Z,13Z,16Z,19Z)/0:0/0:0) is a monoacylglyceride. A monoglyceride, more correctly known as a monoacylglycerol, is a glyceride consisting of one fatty acid chain covalently bonded to a glycerol molecule through an ester linkage. Monoacylglycerol can be broadly divided into two groups; 1-monoacylglycerols (or 3-monoacylglycerols) and 2-monoacylglycerols, depending on the position of the ester bond on the glycerol moiety. Normally the 1-/3-isomers are not distinguished from each other and are termed alpha-monoacylglycerols, while the 2-isomers are beta-monoacylglycerols. Monoacylglycerols are formed biochemically via release of a fatty acid from diacylglycerol by diacylglycerol lipase or hormone sensitive lipase. Monoacylglycerols are broken down by monoacylglycerol lipase. They tend to be minor components only of most plant and animal tissues, and indeed would not be expected to accumulate because their strong detergent properties would have a disruptive effect on membranes. 2-Monoacylglycerols are a major end product of the intestinal digestion of dietary fats in animals via the enzyme pancreatic lipase. They are taken up directly by the intestinal cells and converted to triacylglycerols via the monoacylglycerol pathway before being transported in lymph to the liver. Mono- and Diglycerides are commonly added to commercial food products in small quantities. They act as emulsifiers, helping to mix ingredients such as oil and water that would not otherwise blend well.

   

11'-Carboxy-gamma-chromanol

(4R,8S)-11-[(2R)-6-hydroxy-2,7,8-trimethyl-3,4-dihydro-2H-1-benzopyran-2-yl]-4,8-dimethylundecanoic acid

C25H40O4 (404.2926)


11-Carboxy-gamma-tocopherol is a dehydrogenation carboxylate product of 11-hydroxy-r-tocopherol by an unidentified microsomal enzyme(s) probably via an aldehyde intermediate. r-Tocopherol provides different antioxidant activities in food and in-vitro studies and showed higher activity in trapping lipophilic electrophiles and reactive nitrogen and oxygen species. From the metabolism end product, only that of r-tocopherol (2,7,8-trimethyl-2-(b-carboxyethyl)-6-hydroxychroman), but not that of a-tocopherol, was identified to provide natriuretic activity. Only the r-tocopherol plasma level served as biomarker for cancer and cardiovascular risk. 11-Carboxy-gamma-tocopherol is a dehydrogenation carboxylate product of 11-hydroxy-r-tocopherol by an unidentified microsomal enzyme(s) probably via an aldehyde intermediate

   

1,25-Dihydroxy-19-norvitamin D3

5-{2-[1-(6-hydroxy-6-methylheptan-2-yl)-7a-methyl-octahydro-1H-inden-4-ylidene]ethylidene}cyclohexane-1,3-diol

C26H44O3 (404.329)


   

[(1S,3S,7R,8R,8As)-8-[2-[(4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] (2R)-2-methylbutanoate

[(1S,3S,7R,8R,8As)-8-[2-[(4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] (2R)-2-methylbutanoic acid

C24H36O5 (404.2563)


D057847 - Lipid Regulating Agents > D000960 - Hypolipidemic Agents > D000924 - Anticholesteremic Agents D004791 - Enzyme Inhibitors > D019161 - Hydroxymethylglutaryl-CoA Reductase Inhibitors D009676 - Noxae > D000963 - Antimetabolites

   

Androstane-3,17-diol dipropionate

(10,13-dimethyl-17-propanoyloxy-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl) propanoate

C25H40O4 (404.2926)


   

Cetylmannoside

2-(hexadecyloxy)-6-(hydroxymethyl)oxane-3,4,5-triol

C22H44O6 (404.3138)


   

Cholesteryl chloride

3beta-Chlorocholest-5-ene

C27H45Cl (404.321)


   

Eliglustat

N-[(1R,2R)-1-(2,3-Dihydro-1,4-benzodioxin-6-yl)-1-hydroxy-3-(1-pyrrolidinyl)-2-propanyl]octanamide;eliglustat tartrate

C23H36N2O4 (404.2675)


   

mepitiostane

15-[(1-methoxycyclopentyl)oxy]-2,16-dimethyl-5-thiapentacyclo[9.7.0.0^{2,8}.0^{4,6}.0^{12,16}]octadecane

C25H40O2S (404.2749)


   

6,7-Dihydroudoteal

6,7-Dihydroudoteal

C24H36O5 (404.2563)


   

Gibberosin I

Gibberosin I

C24H36O5 (404.2563)


   

3alpha-Angeloyloxy-ent-labda-7,13E-dien-2beta,15-diol

3alpha-Angeloyloxy-ent-labda-7,13E-dien-2beta,15-diol

C25H40O4 (404.2926)


   

4,4-Diapo-7,8,11,12-tetrahydrolycopene

7,8,11,12-Tetrahydro-4,4-diapo-psi,psi-carotene

C30H44 (404.3443)


   

Briarellin R

Briarellin R

C24H36O5 (404.2563)


   
   

Stolonoxide E

Stolonoxide E

C24H36O5 (404.2563)


   

Gibberosene E

Gibberosene E

C24H36O5 (404.2563)


   

6alpha-Angeloyloxynidorellol

6alpha-Angeloyloxynidorellol

C25H40O4 (404.2926)


   

Bungeiquinone

Bungeiquinone

C25H40O4 (404.2926)


   

Gibberosene F

Gibberosene F

C24H36O5 (404.2563)


   

Sicanatriol 7beta,18-diacetate

Sicanatriol 7beta,18-diacetate

C24H36O5 (404.2563)


   

Erythrophloin C

Erythrophloin C

C28H36O2 (404.2715)


   

3beta-Hydroxy-15-[3-methylvaleryloxy]-ent-labda-7,13E-dien

3beta-Hydroxy-15-[3-methylvaleryloxy]-ent-labda-7,13E-dien

C26H44O3 (404.329)


   

11,15-O,O-Diacetylcyathatriol

11,15-O,O-Diacetylcyathatriol

C24H36O5 (404.2563)


   

phorbasin I

phorbasin I

C24H36O5 (404.2563)


   

23-Methylstigmasta-3,5,7,9(11),22-pentaene

23-Methylstigmasta-3,5,7,9(11),22-pentaene

C30H44 (404.3443)


   

AKOS024419714

AKOS024419714

C24H36O5 (404.2563)


   

5?-CHOLANIC ACID-3?-OL-6_7-DIONE

5?-CHOLANIC ACID-3?-OL-6_7-DIONE

C24H36O5 (404.2563)


CONFIDENCE standard compound; INTERNAL_ID 269

   

Capiquinone C

Capiquinone C

C26H44O3 (404.329)


   

15beta,16-diacetoxy-12(R),15-epoxylabda-8(17),13(16)-diene

15beta,16-diacetoxy-12(R),15-epoxylabda-8(17),13(16)-diene

C24H36O5 (404.2563)


   

2,5-Dihydroxy-3-(nonadec-14-enyl)-benzoquinone

2,5-Dihydroxy-3-(nonadec-14-enyl)-benzoquinone

C25H40O4 (404.2926)


   

Sideritriol 7beta,17-diacetate

Sideritriol 7beta,17-diacetate

C24H36O5 (404.2563)


   

zyggomphic acid B

zyggomphic acid B

C28H36O2 (404.2715)


   
   

Methyl-3alpha,7alpha-dihydroxychol-4-enoat

Methyl-3alpha,7alpha-dihydroxychol-4-enoat

C25H40O4 (404.2926)


   

Nemosenin B = (1beta,10beta-Epoxy-3-hydroxy-6beta-dihydroangelyloxy-furoeremophilan)

Nemosenin B = (1beta,10beta-Epoxy-3-hydroxy-6beta-dihydroangelyloxy-furoeremophilan)

C24H36O5 (404.2563)


   

14,18-diacetylisopusillatriol

14,18-diacetylisopusillatriol

C24H36O5 (404.2563)


   

Malouphyllinin|Malouphyllinol; Malouphyllinin

Malouphyllinin|Malouphyllinol; Malouphyllinin

C25H44N2O2 (404.3403)


   

SCHEMBL15009234

SCHEMBL15009234

C25H40O4 (404.2926)


   

1-(3,4-Dihydroxyphenyl)icosan-5-one

1-(3,4-Dihydroxyphenyl)icosan-5-one

C26H44O3 (404.329)


   

Stachysolon, diacetate

Stachysolon, diacetate

C24H36O5 (404.2563)


   

19-Angeloyloxycativsaeure

19-Angeloyloxycativsaeure

C25H40O4 (404.2926)


   

ent-17-angeloyloxy-3beta,16beta-dihydroxykaurane

ent-17-angeloyloxy-3beta,16beta-dihydroxykaurane

C25H40O4 (404.2926)


   

3-hydroxy-4,6b,8a,11,12b,14a-hexamethyl-7,8,8a,9,12,12a,12b,13,14,14a-decahydropicen-2(6bh)-one

3-hydroxy-4,6b,8a,11,12b,14a-hexamethyl-7,8,8a,9,12,12a,12b,13,14,14a-decahydropicen-2(6bh)-one

C28H36O2 (404.2715)


   

calicophirin B

calicophirin B

C24H36O5 (404.2563)


   

15,16-diacetoxy-15,16-epoxy-neo-cleroda-3,12Z-diene|Di-Ac-15, 16-Epoxy-3, 12-clerodadiene-15, 16-diol

15,16-diacetoxy-15,16-epoxy-neo-cleroda-3,12Z-diene|Di-Ac-15, 16-Epoxy-3, 12-clerodadiene-15, 16-diol

C24H36O5 (404.2563)


   

ent-1beta,1-diacetoxy-12alpha-hydroxy-beyer-15-ene|ent-1beta,17-diacetoxy-12alpha-hydroxybeyer-15-ene

ent-1beta,1-diacetoxy-12alpha-hydroxy-beyer-15-ene|ent-1beta,17-diacetoxy-12alpha-hydroxybeyer-15-ene

C24H36O5 (404.2563)


   

boletinin E

boletinin E

C24H36O5 (404.2563)


   

2-(4-hydroxyphenyl)ethyl octadecanoate

2-(4-hydroxyphenyl)ethyl octadecanoate

C26H44O3 (404.329)


   

1-(4-Hydroxyphenyl)-5-hydroxyicosane-3-one

1-(4-Hydroxyphenyl)-5-hydroxyicosane-3-one

C26H44O3 (404.329)


   

Luffariolide C

Luffariolide C

C25H40O4 (404.2926)


   

conulosin-A ethyl ester

conulosin-A ethyl ester

C26H44O3 (404.329)


   

2alpha,10alpha-diacetoxy-7,8-epoxydolabella-3(E),18-diene

2alpha,10alpha-diacetoxy-7,8-epoxydolabella-3(E),18-diene

C24H36O5 (404.2563)


   

7beta,18-dihydroxy-ent-beyer-15-en-18-O-succinate

7beta,18-dihydroxy-ent-beyer-15-en-18-O-succinate

C24H36O5 (404.2563)


   

ACMC-20n3kk

ACMC-20n3kk

C26H44O3 (404.329)


   
   

(1Z,3E,7E,11S,12R,13S,14R)-13,14-diacetoxy-11,12-epoxy cembra-1,3,7-triene|flaccidoxide-13-acetate

(1Z,3E,7E,11S,12R,13S,14R)-13,14-diacetoxy-11,12-epoxy cembra-1,3,7-triene|flaccidoxide-13-acetate

C24H36O5 (404.2563)


   

16alphaH,17-isovaleroyloxy-ent-kauran-19-oic acid

16alphaH,17-isovaleroyloxy-ent-kauran-19-oic acid

C25H40O4 (404.2926)


   

7-ketolithocholic Methyl ester

(R)-Methyl 4-((3R,5S,8R,9S,10S,13R,14S,17R)-3-hydroxy-10,13-dimethyl-7-oxohexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoate

C25H40O4 (404.2926)


   

(5E,9E)-2-(acetyloxy)-2-[(E)-2-(acetyloxy)ethenyl]-6,10,14-trimethyl-5,9,13-pentadecatrienal

(5E,9E)-2-(acetyloxy)-2-[(E)-2-(acetyloxy)ethenyl]-6,10,14-trimethyl-5,9,13-pentadecatrienal

C24H36O5 (404.2563)


   

Di-Ac-5-Pentadecyl-1,3-benzenediol

Di-Ac-5-Pentadecyl-1,3-benzenediol

C25H40O4 (404.2926)


   

Di-Ac-15,16-Dihydroxy-12-isocopalen-11-one

Di-Ac-15,16-Dihydroxy-12-isocopalen-11-one

C24H36O5 (404.2563)


   

(1S*,4S*,9R*,11S*,14Z)-12,16-diacetoxyxeniaphylla-8(19),14-dien-5-one|gibberosin S

(1S*,4S*,9R*,11S*,14Z)-12,16-diacetoxyxeniaphylla-8(19),14-dien-5-one|gibberosin S

C24H36O5 (404.2563)


   

11alpha-acetoxy-3,3-dimethoxy-5alpha-pregn-20-ene

11alpha-acetoxy-3,3-dimethoxy-5alpha-pregn-20-ene

C25H40O4 (404.2926)


   

pentadecanoic acid beta-D-glucoside

pentadecanoic acid beta-D-glucoside

C21H40O7 (404.2774)


   

5,8-Di-Ac-Mutilin

5,8-Di-Ac-Mutilin

C24H36O5 (404.2563)


   

SCHEMBL13648593

SCHEMBL13648593

C26H44O3 (404.329)


   

Junceanol W

Junceanol W

C25H40O4 (404.2926)


   

16-(2-methylbutyryloxy)-ent-labda-8(17),13Z-dien-15-oic acid|16-<2-methylbutyryloxy>-ent-labda-8(17),13Z-dien-15-oic acid

16-(2-methylbutyryloxy)-ent-labda-8(17),13Z-dien-15-oic acid|16-<2-methylbutyryloxy>-ent-labda-8(17),13Z-dien-15-oic acid

C25H40O4 (404.2926)


   

2,3-Di-Ac-2,3,9-Trinervitriol

2,3-Di-Ac-2,3,9-Trinervitriol

C24H36O5 (404.2563)


   

(6S,7R,14S)-6,7-diacetoxydolasta-1(15),8-dien-14-ol|6,7-Di-Ac 鈥樎?6S,7R,14S)-1(15),8-Dolastadiene-6,7,14-triol

(6S,7R,14S)-6,7-diacetoxydolasta-1(15),8-dien-14-ol|6,7-Di-Ac 鈥樎?6S,7R,14S)-1(15),8-Dolastadiene-6,7,14-triol

C24H36O5 (404.2563)


   

ent-3beta-angeloyloxy-16beta,17-dihydroxykaurane

ent-3beta-angeloyloxy-16beta,17-dihydroxykaurane

C25H40O4 (404.2926)


   

3,6-diacetylcladiellisin

3,6-diacetylcladiellisin

C24H36O5 (404.2563)


   
   

1,1,1-(dodecahydro-1,4,7,9b-tetrazaphenalene)tri-1,2-propanediol

1,1,1-(dodecahydro-1,4,7,9b-tetrazaphenalene)tri-1,2-propanediol

C18H36N4O6 (404.2635)


   
   

Di-Ac-15-17-Dihydroxy-3,13-clerodadien-2-one

Di-Ac-15-17-Dihydroxy-3,13-clerodadien-2-one

C24H36O5 (404.2563)


   

13beta,18-diacetoxyabiet-8(14)-en-7-one

13beta,18-diacetoxyabiet-8(14)-en-7-one

C24H36O5 (404.2563)


   

1,12-jativatriol diacetate|ent-1beta,12alpha-diacetoxy-17-hydroxybeyer-15-ene

1,12-jativatriol diacetate|ent-1beta,12alpha-diacetoxy-17-hydroxybeyer-15-ene

C24H36O5 (404.2563)


   

4,6-Di-Ac 鈥樎?4beta,6alpha,14beta)-1(15),8-Dolastadiene-4,6,14-triol

4,6-Di-Ac 鈥樎?4beta,6alpha,14beta)-1(15),8-Dolastadiene-4,6,14-triol

C24H36O5 (404.2563)


   

dictyotriol A diacetate

dictyotriol A diacetate

C24H36O5 (404.2563)


   

methyl (3alpha)-3-hydroxy-12-oxocholan-24-oate

methyl (3alpha)-3-hydroxy-12-oxocholan-24-oate

C25H40O4 (404.2926)


   

asbestinin-9

asbestinin-9

C24H36O5 (404.2563)


   

trunculin A, methyl ester

trunculin A, methyl ester

C25H40O4 (404.2926)


   
   

secorpatacetal D

secorpatacetal D

C24H36O5 (404.2563)


   

3-epi-periplogenin

3-epi-periplogenin

C24H36O5 (404.2563)


   

2-hydroxy-6-nonadecylbenzoic acid

2-hydroxy-6-nonadecylbenzoic acid

C26H44O3 (404.329)


   

12beta-O-acetyl-15alpha,28-dihydoxy-3-oxo-17-en-20,21,22,23,24,25,26,27-octanordammanran

12beta-O-acetyl-15alpha,28-dihydoxy-3-oxo-17-en-20,21,22,23,24,25,26,27-octanordammanran

C24H36O5 (404.2563)


   

Ergosterol peroxide

Ergosterol peroxide

C24H36O5 (404.2563)


   

12Z-(heptadec-12-enyl)-4-hydroxy-3,4,7,8-tetrahydro-2H-chromen-5(6H)-one

12Z-(heptadec-12-enyl)-4-hydroxy-3,4,7,8-tetrahydro-2H-chromen-5(6H)-one

C26H44O3 (404.329)


   

19-acetoxy-3,3-dimethoxy-5alpha-pregn-20-ene|sclerosteroid J

19-acetoxy-3,3-dimethoxy-5alpha-pregn-20-ene|sclerosteroid J

C25H40O4 (404.2926)


   

19-(beta-Carboxy-n-propionyloxy)-(-)-Delta16-kauren-3alpha-ol

19-(beta-Carboxy-n-propionyloxy)-(-)-Delta16-kauren-3alpha-ol

C24H36O5 (404.2563)


   

15(R)-n-butoxypinusolidic acid

15(R)-n-butoxypinusolidic acid

C24H36O5 (404.2563)


   

glycerol mono-(E)-8,11,12-trihydroxy-9-octadecenoate

glycerol mono-(E)-8,11,12-trihydroxy-9-octadecenoate

C21H40O7 (404.2774)


   

antcamphin A

antcamphin A

C24H36O5 (404.2563)


   

bebryceoid A

bebryceoid A

C26H44O3 (404.329)


   

hexadecyl ferulic acid|pentadecyl ferulate

hexadecyl ferulic acid|pentadecyl ferulate

C25H40O4 (404.2926)


   

3-Pentadecacatechol diacetate

3-Pentadecacatechol diacetate

C25H40O4 (404.2926)


   

Hexanorcucurbitacin F

Hexanorcucurbitacin F

C24H36O5 (404.2563)


   

conulosin-B ethyl ester

conulosin-B ethyl ester

C26H44O3 (404.329)


   

15-succinoxy-8(17),E-13-labdadien-19-al

15-succinoxy-8(17),E-13-labdadien-19-al

C24H36O5 (404.2563)


   
   

3alpha-angeloyloxy-15,18-dihydroxy-ent-labda-8(17),13E-diene

3alpha-angeloyloxy-15,18-dihydroxy-ent-labda-8(17),13E-diene

C25H40O4 (404.2926)


   

Junceanol X

Junceanol X

C25H40O4 (404.2926)


   

plakortolide S

plakortolide S

C24H36O5 (404.2563)


An organic heterobicyclic compound that is a cyclic peroxy compound isolated from the Australian marine sponge Plakinastrella clathrata.

   

plakinic acid L

plakinic acid L

C25H40O4 (404.2926)


   

turraeanin A|[16(E),12S,15R]-16-acetoxy-12,15-epoxy-15-isopropoxy-ent-labda-8(17),13(16)-diene

turraeanin A|[16(E),12S,15R]-16-acetoxy-12,15-epoxy-15-isopropoxy-ent-labda-8(17),13(16)-diene

C25H40O4 (404.2926)


   

Sculponeatin N

[(1R,2S,4R,9R,10S,13R,14R)-2,14-dihydroxy-5,5,9-trimethyl-14-tetracyclo[11.2.1.01,10.04,9]hexadecanyl]methyl 3-methylbut-2-enoate

C25H40O4 (404.2926)


   

3,7,11-trimethyl-n-hexadecan-10beta-ol-1-yl benzoate|orizanorditerpenyl benzoate

3,7,11-trimethyl-n-hexadecan-10beta-ol-1-yl benzoate|orizanorditerpenyl benzoate

C26H44O3 (404.329)


   

Methyl 6-(pentadec-8Z-enyl)-2,4-dimethoxybenzoate

Methyl 6-(pentadec-8Z-enyl)-2,4-dimethoxybenzoate

C25H40O4 (404.2926)


   

3-(2-Methylpropanoyl)-(ent-3beta)-3, 9-Dihydroxy-15-kauren-19-oic acid

3-(2-Methylpropanoyl)-(ent-3beta)-3, 9-Dihydroxy-15-kauren-19-oic acid

C24H36O5 (404.2563)


   
   

plakinic acid I

plakinic acid I

C25H40O4 (404.2926)


   

debilisone B

debilisone B

C25H40O4 (404.2926)


   

ent-6beta,17-diacetoxy-labda-7,11E,14-triene-13-ol

ent-6beta,17-diacetoxy-labda-7,11E,14-triene-13-ol

C24H36O5 (404.2563)


   

3,14-diacetylisopusillatriol

3,14-diacetylisopusillatriol

C24H36O5 (404.2563)


   

(14E)-O15-acetyl-13-(acetyloxy)-20-oxo-4,15-didehydro-6,7,8,11,12,13-hexahydroretinol

(14E)-O15-acetyl-13-(acetyloxy)-20-oxo-4,15-didehydro-6,7,8,11,12,13-hexahydroretinol

C24H36O5 (404.2563)


   

Me ester-(3alpha,5beta)-3-Hydroxy-6-oxocholan-24-oic acid

Me ester-(3alpha,5beta)-3-Hydroxy-6-oxocholan-24-oic acid

C25H40O4 (404.2926)


   

8beta,12beta-dihydroxy-11alpha-senecioyloxy-sandaracopimar-15-ene

8beta,12beta-dihydroxy-11alpha-senecioyloxy-sandaracopimar-15-ene

C25H40O4 (404.2926)


   

15,16-diacetoxy-15,16-epoxy-ent-cleroda-4(18),12Z-diene|Di-Ac 鈥樎?ent-12Z,15xi,16xi)-15,16-Epoxy-4(18),12-clerodadiee-15,16-diol

15,16-diacetoxy-15,16-epoxy-ent-cleroda-4(18),12Z-diene|Di-Ac 鈥樎?ent-12Z,15xi,16xi)-15,16-Epoxy-4(18),12-clerodadiee-15,16-diol

C24H36O5 (404.2563)


   

3beta-hydroxy-15-(3-methylvaleryloxy)-ent-labda-7,13E-diene|3beta-hydroxy-15-<3-methylvaleryloxy>-ent-labda-7,13E-diene

3beta-hydroxy-15-(3-methylvaleryloxy)-ent-labda-7,13E-diene|3beta-hydroxy-15-<3-methylvaleryloxy>-ent-labda-7,13E-diene

C26H44O3 (404.329)


   

ent-16,17-acetonyl-(-)-kauran-19-oic acid

ent-16,17-acetonyl-(-)-kauran-19-oic acid

C25H40O4 (404.2926)


   

ethyl trixagoyl malonate

ethyl trixagoyl malonate

C25H40O4 (404.2926)


   

12-O-Deacetoxyl-24-hydroxyl-deoxoscalarin

12-O-Deacetoxyl-24-hydroxyl-deoxoscalarin

C25H40O4 (404.2926)


   

boletinin F

boletinin F

C24H36O5 (404.2563)


   

barangcadoic acid A

barangcadoic acid A

C25H40O4 (404.2926)


   

4(SR),7(SR)-diacetoxy-14(SR)-hydroxydolast-1(15),8-diene

4(SR),7(SR)-diacetoxy-14(SR)-hydroxydolast-1(15),8-diene

C24H36O5 (404.2563)


   

8beta,12beta-dihydroxy-11alpha-tiglinoyloxy-sandaracopimar-15-ene

8beta,12beta-dihydroxy-11alpha-tiglinoyloxy-sandaracopimar-15-ene

C25H40O4 (404.2926)


   

15,17-Diacetoxy-12-isocopalen-16-al

15,17-Diacetoxy-12-isocopalen-16-al

C24H36O5 (404.2563)


   

10R,13S-dihydroxy-4,8,12-trimethyl-1-(1-methylethenyl)-3(E),7(E),11(E)-cyclotetradecatriene 3-hydroxy-2-methylbutan-10-oate|cleospinol A 3-hydroxy-2-methylbutan-10-oate

10R,13S-dihydroxy-4,8,12-trimethyl-1-(1-methylethenyl)-3(E),7(E),11(E)-cyclotetradecatriene 3-hydroxy-2-methylbutan-10-oate|cleospinol A 3-hydroxy-2-methylbutan-10-oate

C25H40O4 (404.2926)


   

DTXSID001000695

DTXSID001000695

C28H36O2 (404.2715)


   

Lovastatin

Lovastatin (Mevacor)

C24H36O5 (404.2563)


C - Cardiovascular system > C10 - Lipid modifying agents > C10A - Lipid modifying agents, plain > C10AA - Hmg coa reductase inhibitors D057847 - Lipid Regulating Agents > D000960 - Hypolipidemic Agents > D000924 - Anticholesteremic Agents D004791 - Enzyme Inhibitors > D019161 - Hydroxymethylglutaryl-CoA Reductase Inhibitors C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent C471 - Enzyme Inhibitor > C1655 - HMG-CoA Reductase Inhibitor CONFIDENCE standard compound; INTERNAL_ID 2212 D009676 - Noxae > D000963 - Antimetabolites relative retention time with respect to 9-anthracene Carboxylic Acid is 1.415 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.416 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.421 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.419 Lovastatin is a cell-permeable HMG-CoA reductase inhibitor used to lower cholesterol. Lovastatin is a cell-permeable HMG-CoA reductase inhibitor used to lower cholesterol.

   

MLS000069585-01!

MLS000069585-01!

C24H36O5 (404.2563)


   

C24H36O5_(1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-Hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydro-1-naphthalenyl (2S)-2-methylbutanoate

NCGC00023509-16_C24H36O5_(1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-Hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydro-1-naphthalenyl (2S)-2-methylbutanoate

C24H36O5 (404.2563)


   

5?-CHOLANIC ACID-3?-OL-7_12-DIONE

5?-CHOLANIC ACID-3?-OL-7_12-DIONE

C24H36O5 (404.2563)


CONFIDENCE standard compound; INTERNAL_ID 266

   

Lovastatin M+H; Mevinolin annotated in standard

Lovastatin M+H; Mevinolin annotated in standard

C24H36O5 (404.2563)


   
   

Lovastatin related molecule observed in standard

Lovastatin related molecule observed in standard

C24H36O5 (404.2563)


   

Lovastatin M+Na; Mevinolin

Lovastatin M+Na; Mevinolin

C24H36O5 (404.2563)


   

Lovastatin M+NH4; Mevinolin

Lovastatin M+NH4; Mevinolin

C24H36O5 (404.2563)


   

Lovastatin related ion M+H ; Mevinolin annotated in standard

Lovastatin related ion M+H ; Mevinolin annotated in standard

C24H36O5 (404.2563)


   

methyl (4R,E)-4-((3R,5S,7S,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pent-2-enoate

"methyl (4R,E)-4-((3R,5S,7S,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pent-2-enoate"

C25H40O4 (404.2926)


   

(R)-4-((3R,5S,8R,9S,10S,13R,14S,17R)-3-hydroxy-10,13-dimethyl-7,12-dioxohexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid

"(R)-4-((3R,5S,8R,9S,10S,13R,14S,17R)-3-hydroxy-10,13-dimethyl-7,12-dioxohexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid"

C24H36O5 (404.2563)


   

1α,25-dihydroxy-21-nor-20-oxavitamin D3 / 1α,25-dihydroxy-21-nor-20-oxacholecalciferol

1α,25-dihydroxy-21-nor-20-oxavitamin D3 / 1α,25-dihydroxy-21-nor-20-oxacholecalciferol

C25H40O4 (404.2926)


   

1α,25-dihydroxy-24-nor-22-oxavitamin D3 / 1α,25-dihydroxy-24-nor-22-oxacholecalciferol

1α,25-dihydroxy-24-nor-22-oxavitamin D3 / 1α,25-dihydroxy-24-nor-22-oxacholecalciferol

C25H40O4 (404.2926)


   

1α,25-dihydroxy-19-norvitamin D3 / 1α,25-dihydroxy-19-norcholecalciferol

1α,25-dihydroxy-19-norvitamin D3 / 1α,25-dihydroxy-19-norcholecalciferol

C26H44O3 (404.329)


   

1,25-dihydroxy-2-nor-1,2-secovitamin D3 / 1,25-dihydroxy-2-nor-1,2-secocholecalciferol

1,25-dihydroxy-2-nor-1,2-secovitamin D3 / 1,25-dihydroxy-2-nor-1,2-secocholecalciferol

C26H44O3 (404.329)


   

2-Nor-1,3-seco-1α,25-dihydroxyvitamin D3

(5ZE,7E)-2-nor-1,3-seco-9,10-seco-5,7,10(19)-cholestatriene-1,3,25-triol

C26H44O3 (404.329)


   

3α-Hydroxy-7,12-dioxo-5β-cholan-24-oic Acid

3α-Hydroxy-7,12-dioxo-5β-cholan-24-oic Acid

C24H36O5 (404.2563)


   

3β-Hydroxy-7,12-dioxo-5β-cholan-24-oic Acid

3β-Hydroxy-7,12-dioxo-5β-cholan-24-oic Acid

C24H36O5 (404.2563)


   

7α-Hydroxy-3,12-dioxo-5β-cholan-24-oic Acid

7α-Hydroxy-3,12-dioxo-5β-cholan-24-oic Acid

C24H36O5 (404.2563)


   

7β-Hydroxy-3,12-dioxo-5β-cholan-24-oic Acid

7β-Hydroxy-3,12-dioxo-5β-cholan-24-oic Acid

C24H36O5 (404.2563)


   

12α-Hydroxy-3,7-dioxo-5β-cholan-24-oic Acid

12α-Hydroxy-3,7-dioxo-5β-cholan-24-oic Acid

C24H36O5 (404.2563)


   

12α-Hydroxy-3,7-dioxo-5α-cholan-24-oic Acid

12α-Hydroxy-3,7-dioxo-5α-cholan-24-oic Acid

C24H36O5 (404.2563)


   

6β,12α-Dihydroxy-3-oxochol-4-en-24-oic Acid

6β,12α-Dihydroxy-3-oxochol-4-en-24-oic Acid

C24H36O5 (404.2563)


   

3α-Hydroxy-1,7-dioxo-5β-cholan-24-oic Acid

3α-Hydroxy-1,7-dioxo-5β-cholan-24-oic Acid

C24H36O5 (404.2563)


   

2β,3β-Dihydroxy-6-oxo-5α-chol-7-en-24-oic Acid

2β,3β-Dihydroxy-6-oxo-5α-chol-7-en-24-oic Acid

C24H36O5 (404.2563)


   

3α,11-Dihydroxy-12-oxo-5β-chol-9(11)-en-24-oic Acid

3α,11-Dihydroxy-12-oxo-5β-chol-9(11)-en-24-oic Acid

C24H36O5 (404.2563)


   

(23R)-23-Hydroxy-3,7-dioxo-5β-cholan-24-oic Acid

(23R)-23-Hydroxy-3,7-dioxo-5β-cholan-24-oic Acid

C24H36O5 (404.2563)


   

3α,12α-Dihydroxy-15-oxo-5β-chol-8(14)-en-24-oic Acid

3α,12α-Dihydroxy-15-oxo-5β-chol-8(14)-en-24-oic Acid

C24H36O5 (404.2563)


   

3α-Hydroxy-11,12-dioxo-5β-cholan-24-oic Acid

3α-Hydroxy-11,12-dioxo-5β-cholan-24-oic Acid

C24H36O5 (404.2563)


   

3α,12α-Dihydroxy-6-oxo-5β-chol-7-en-24-oic Acid

3α,12α-Dihydroxy-6-oxo-5β-chol-7-en-24-oic Acid

C24H36O5 (404.2563)


   

3α,7α-Dihydroxy-12-oxo-5β-chol-9(11)-en-24-oic Acid

3α,7α-Dihydroxy-12-oxo-5β-chol-9(11)-en-24-oic Acid

C24H36O5 (404.2563)


   

12α-Hydroxy-3,6-dioxo-5β-cholan-24-oic Acid

12α-Hydroxy-3,6-dioxo-5β-cholan-24-oic Acid

C24H36O5 (404.2563)


   

4,12α-Dihydroxy-3-oxochol-4-en-24-oic Acid

4,12α-Dihydroxy-3-oxochol-4-en-24-oic Acid

C24H36O5 (404.2563)


   

2,12α-Dihydroxy-3-oxo-5β-chol-1-en-24-oic Acid

2,12α-Dihydroxy-3-oxo-5β-chol-1-en-24-oic Acid

C24H36O5 (404.2563)


   

6α-Hydroxy-3,7-dioxo-5β-cholan-24-oic Acid

6α-Hydroxy-3,7-dioxo-5β-cholan-24-oic Acid

C24H36O5 (404.2563)


   

7b-Hydroxy-3-oxo-5b-cholan-24-oate

7b-Hydroxy-3-oxo-5b-cholan-24-oate

C25H40O4 (404.2926)


   

MG(22:5)

1-(7Z,10Z,13Z,16Z,19Z-docosapentaenoyl)-rac-glycerol

C25H40O4 (404.2926)


   

4,12alpha-Dihydroxy-3-oxochol-4-en-24-oic Acid

4,12alpha-Dihydroxy-3-oxochol-4-en-24-oic Acid

C24H36O5 (404.2563)


   

2,12alpha-Dihydroxy-3-oxo-5beta-chol-1-en-24-oic Acid

2,12alpha-Dihydroxy-3-oxo-5beta-chol-1-en-24-oic Acid

C24H36O5 (404.2563)


   

6alpha-Hydroxy-3,7-dioxo-5beta-cholan-24-oic Acid

6alpha-Hydroxy-3,7-dioxo-5beta-cholan-24-oic Acid

C24H36O5 (404.2563)


   

Lucidone C

14-acetyl-5,9,12-trihydroxy-2,6,6,11,15-pentamethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-1(10)-en-17-one

C24H36O5 (404.2563)


   

Ventosic acid

9,10,12,13-tetrahydroxydocosanoic acid

C22H44O6 (404.3138)


   

bhas#26

3R-hydroxy-14R-(3R,5R-dihydroxy-6S-methyl-(2H)-tetrahydropyran-2-yloxy)-pentadecanoic acid

C21H40O7 (404.2774)


An (omega-1)-hydroxy fatty acid ascaroside that is ascr#26 in which the pro-R hydrogen that is beta to the carboxy group is replaced by a hydroxy group. It is a metabolite of the nematode Caenorhabditis elegans.

   

bhos#26

3R-hydroxy-15-(3R,5R-dihydroxy-6S-methyl-(2H)-tetrahydropyran-2-yloxy)-pentadecanoic acid

C21H40O7 (404.2774)


An omega-hydroxy fatty acid ascaroside that is oscr#26 in which the pro-R hydrogen beta to the carboxy group is replaced by a hydroxy group. It is a metabolite of the nematode Caenorhabditis elegans.

   

MG 22:5

2-(22:5(7Z,10Z,13Z,16Z,19Z-docosapentaenoyl)-sn-glycerol

C25H40O4 (404.2926)


   

1alpha,25-dihydroxy-21-nor-20-oxavitamin D3 / 1alpha,25-dihydroxy-21-nor-20-oxacholecalciferol

1alpha,25-dihydroxy-21-nor-20-oxavitamin D3 / 1alpha,25-dihydroxy-21-nor-20-oxacholecalciferol

C25H40O4 (404.2926)


   

1alpha,25-dihydroxy-24-nor-22-oxavitamin D3 / 1alpha,25-dihydroxy-24-nor-22-oxacholecalciferol

1alpha,25-dihydroxy-24-nor-22-oxavitamin D3 / 1alpha,25-dihydroxy-24-nor-22-oxacholecalciferol

C25H40O4 (404.2926)


   

1alpha,25-dihydroxy-19-norvitamin D3 / 1alpha,25-dihydroxy-19-norcholecalciferol

1alpha,25-dihydroxy-19-norvitamin D3 / 1alpha,25-dihydroxy-19-norcholecalciferol

C26H44O3 (404.329)


   

1,25-dihydroxy-2-nor-1,2-secovitamin D3

(5Z,7E)-A-nor-(1,2)-(9,10)-diseco-5,7,10(19)-cholestatriene-1,3,25-triol

C26H44O3 (404.329)


   

2-Nor-1,3-seco-1alpha,25-dihydroxyvitamin D3

(5ZE,7E)-2-nor-1,3-seco-9,10-seco-5,7,10(19)-cholestatriene-1,3,25-triol

C26H44O3 (404.329)


   

ST 24:3;O5

3alpha,12alpha-Dihydroxy-15-oxo-5beta-chol-8(14)-en-24-oic Acid

C24H36O5 (404.2563)


   

ST 26:1;O3

24-dihomo-3alpha-hydroxy-5beta-cholan-26-oic acid

C26H44O3 (404.329)


   

ST 25:2;O4

7b-Hydroxy-3-oxo-5b-cholan-24-oate

C25H40O4 (404.2926)


   
   

Austroyunone B

Austroyunone B

C25H40O4 (404.2926)


   

Mepitiostane

Mepitiostane

C25H40O2S (404.2749)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D004965 - Estrogen Antagonists D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D045930 - Anabolic Agents C274 - Antineoplastic Agent > C129818 - Antineoplastic Hormonal/Endocrine Agent > C481 - Antiestrogen C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist D000970 - Antineoplastic Agents

   

Methyl 7a,12a-dihydroxy-5b-chol-3-enoate

Methyl 7a,12a-dihydroxy-5b-chol-3-enoate

C25H40O4 (404.2926)


   

(5beta,7alpha,12alpha)-7,12-Dihydroxychol-2-en-24-oic acid methyl ester

(5beta,7alpha,12alpha)-7,12-Dihydroxychol-2-en-24-oic acid methyl ester

C25H40O4 (404.2926)


   

3-(2-dodecenyl)-1-(2,2,6,6-tetramethyl-4-piperidyl)pyrrolidine-2,5-dione

3-(2-dodecenyl)-1-(2,2,6,6-tetramethyl-4-piperidyl)pyrrolidine-2,5-dione

C25H44N2O2 (404.3403)


   

Epi Lovastatin

Epi Lovastatin

C24H36O5 (404.2563)


   

Cholesteryl chloride

3-Chlorocholest-5-ene

C27H45Cl (404.321)


   
   

Eliglustat

Eliglustat

C23H36N2O4 (404.2675)


A - Alimentary tract and metabolism > A16 - Other alimentary tract and metabolism products > A16A - Other alimentary tract and metabolism products > A16AX - Various alimentary tract and metabolism products D004791 - Enzyme Inhibitors C471 - Enzyme Inhibitor

   

7,12-dioxolitocholic acid

3-Hydroxy-7,12-diketocholanoic acid

C24H36O5 (404.2563)


D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids

   

Benzyloxycarbonylsarcosin*Dicyclohexylamin-Salz

Benzyloxycarbonylsarcosin*Dicyclohexylamin-Salz

C23H36N2O4 (404.2675)


   

1-(Hexadecyl)-3-methylimidazolium hydrogen sulfate

1-(Hexadecyl)-3-methylimidazolium hydrogen sulfate

C20H39N2.HO4S (404.2709)


   

Dihydrospinosyn A aglycone

Dihydrospinosyn A aglycone

C24H36O5 (404.2563)


   

1-(Tetrahydro-2H-pyran-2-yl)-3,5-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole

1-(Tetrahydro-2H-pyran-2-yl)-3,5-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole

C20H34B2N2O5 (404.2654)


   

hexadecyl D-glucoside

hexadecyl D-glucoside

C22H44O6 (404.3138)


   

2,3-BIS(2,6-DI-I-PROPYLPHENYLIMINO)BUTANE

2,3-BIS(2,6-DI-I-PROPYLPHENYLIMINO)BUTANE

C28H40N2 (404.3191)


   

2-DECYL-1,4,7,10,13,16-HEXAOXACYCLO-OCTADECANE

2-DECYL-1,4,7,10,13,16-HEXAOXACYCLO-OCTADECANE

C22H44O6 (404.3138)


   

(3R,14R)-14-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]-3-hydroxypentadecanoic acid

(3R,14R)-14-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]-3-hydroxypentadecanoic acid

C21H40O7 (404.2774)


   

(3R)-15-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]-3-hydroxypentadecanoic acid

(3R)-15-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]-3-hydroxypentadecanoic acid

C21H40O7 (404.2774)


   

1alpha,25-dihydroxy-24-nor-22-oxavitamin D3/1alpha,25-dihydroxy-24-nor-22-oxacholecalciferol

1alpha,25-dihydroxy-24-nor-22-oxavitamin D3/1alpha,25-dihydroxy-24-nor-22-oxacholecalciferol

C25H40O4 (404.2926)


   

6,7-Diketolithocholic acid

6,7-Diketolithocholic acid

C24H36O5 (404.2563)


6,7-Diketolithocholic acid, also known as 3α,7α,12α-trihydroxy-5β-cholan-24-oic acid, is a derivative of lithocholic acid, which is a secondary bile acid. Bile acids are synthesized in the liver from cholesterol and are important for the digestion and absorption of dietary fats and oils. They are also involved in the transport of hydrophobic lipid molecules in the bloodstream. The presence of two ketone groups (diketo form) at the 6th and 7th positions of the steroid nucleus differentiates 6,7-Diketolithocholic acid from other bile acids. This structural modification can affect its physicochemical properties, such as solubility and hydrophobicity, which in turn can influence its biological activity and interaction with other molecules. In the context of bile acid metabolism, 6,7-Diketolithocholic acid may have implications in certain disease states. For example, it has been associated with cholestasis, a condition where bile flow from the liver is reduced, leading to bile accumulation and potential liver damage. The diketo form of lithocholic acid can also be involved in the pathogenesis of certain liver diseases, including liver cancer. Research on 6,7-Diketolithocholic acid and its derivatives is ongoing, and scientists are exploring their potential as therapeutic agents or as tools to better understand bile acid metabolism and related disorders.

   

(S)-2-Methyl-butyric acid (1S,3R,7S,8S,8aR)-8-[2-((R)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydro-naphthalen-1-yl ester

(S)-2-Methyl-butyric acid (1S,3R,7S,8S,8aR)-8-[2-((R)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydro-naphthalen-1-yl ester

C24H36O5 (404.2563)


   

(3S,5R,10R,12S,14S,15R,16R)-3,5,10,14,15-pentahydroxy-12,16-dimethylicosan-2-one

(3S,5R,10R,12S,14S,15R,16R)-3,5,10,14,15-pentahydroxy-12,16-dimethylicosan-2-one

C22H44O6 (404.3138)


A pentol that is 12,16-dimethylicosan-2-one in which the five hydroxy substituents are located at positions 3, 5, 10, 14 and 15.

   

5-[(2E)-2-[1-(6-hydroxy-6-methylheptan-2-yl)-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]cyclohexane-1,3-diol

5-[(2E)-2-[1-(6-hydroxy-6-methylheptan-2-yl)-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]cyclohexane-1,3-diol

C26H44O3 (404.329)


   

[3-Carboxy-2-(3,11-dihydroxytetradecanoyloxy)propyl]-trimethylazanium

[3-Carboxy-2-(3,11-dihydroxytetradecanoyloxy)propyl]-trimethylazanium

C21H42NO6+ (404.3012)


   

[3-Carboxy-2-(3,7-dihydroxytetradecanoyloxy)propyl]-trimethylazanium

[3-Carboxy-2-(3,7-dihydroxytetradecanoyloxy)propyl]-trimethylazanium

C21H42NO6+ (404.3012)


   

[3-Carboxy-2-(3,13-dihydroxytetradecanoyloxy)propyl]-trimethylazanium

[3-Carboxy-2-(3,13-dihydroxytetradecanoyloxy)propyl]-trimethylazanium

C21H42NO6+ (404.3012)


   

[3-Carboxy-2-(3,8-dihydroxytetradecanoyloxy)propyl]-trimethylazanium

[3-Carboxy-2-(3,8-dihydroxytetradecanoyloxy)propyl]-trimethylazanium

C21H42NO6+ (404.3012)


   

[3-Carboxy-2-(3,4-dihydroxytetradecanoyloxy)propyl]-trimethylazanium

[3-Carboxy-2-(3,4-dihydroxytetradecanoyloxy)propyl]-trimethylazanium

C21H42NO6+ (404.3012)


   

[3-Carboxy-2-(3,5-dihydroxytetradecanoyloxy)propyl]-trimethylazanium

[3-Carboxy-2-(3,5-dihydroxytetradecanoyloxy)propyl]-trimethylazanium

C21H42NO6+ (404.3012)


   

[3-Carboxy-2-(3,10-dihydroxytetradecanoyloxy)propyl]-trimethylazanium

[3-Carboxy-2-(3,10-dihydroxytetradecanoyloxy)propyl]-trimethylazanium

C21H42NO6+ (404.3012)


   

[3-Carboxy-2-(3,12-dihydroxytetradecanoyloxy)propyl]-trimethylazanium

[3-Carboxy-2-(3,12-dihydroxytetradecanoyloxy)propyl]-trimethylazanium

C21H42NO6+ (404.3012)


   

[3-Carboxy-2-(3,6-dihydroxytetradecanoyloxy)propyl]-trimethylazanium

[3-Carboxy-2-(3,6-dihydroxytetradecanoyloxy)propyl]-trimethylazanium

C21H42NO6+ (404.3012)


   

[3-Carboxy-2-(3,9-dihydroxytetradecanoyloxy)propyl]-trimethylazanium

[3-Carboxy-2-(3,9-dihydroxytetradecanoyloxy)propyl]-trimethylazanium

C21H42NO6+ (404.3012)


   

Isoiguesterin

Isoiguesterin

C28H36O2 (404.2715)


A pentacyclic triterpenoid that is a bisnortriterpene isolated from Salacia madagascariensis and exhibits antileishmanial and antileukemic activities.

   

(1R,6R)-6-[(2E,6E)-11-hydroxy-3,7,11-trimethyldodeca-2,6-dien-1-yl]-3-methyl-5-oxo-7-oxabicyclo[4.1.0]hept-3-en-2-yl acetate

(1R,6R)-6-[(2E,6E)-11-hydroxy-3,7,11-trimethyldodeca-2,6-dien-1-yl]-3-methyl-5-oxo-7-oxabicyclo[4.1.0]hept-3-en-2-yl acetate

C24H36O5 (404.2563)


   

1,3,2-Dioxaphospholane, 2-hydroxy-4-[[(9Z)-9-octadecen-1-yloxy]methyl]-, 2-oxide, (4R)-

1,3,2-Dioxaphospholane, 2-hydroxy-4-[[(9Z)-9-octadecen-1-yloxy]methyl]-, 2-oxide, (4R)-

C21H41O5P (404.2691)


   

(2S)-2-methylbutanoic acid [(7S,8S,8aR)-8-[2-[(2R)-4-hydroxy-6-oxo-2-oxanyl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] ester

(2S)-2-methylbutanoic acid [(7S,8S,8aR)-8-[2-[(2R)-4-hydroxy-6-oxo-2-oxanyl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] ester

C24H36O5 (404.2563)


   

methyl (4R,E)-4-((3R,5S,7S,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pent-2-enoate

methyl (4R,E)-4-((3R,5S,7S,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pent-2-enoate

C25H40O4 (404.2926)


   

(2S)-2-methylbutanoic acid [(1S,3R,7S,8S,8aS)-8-[2-[(2R,4R)-4-hydroxy-6-oxo-2-oxanyl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] ester

(2S)-2-methylbutanoic acid [(1S,3R,7S,8S,8aS)-8-[2-[(2R,4R)-4-hydroxy-6-oxo-2-oxanyl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] ester

C24H36O5 (404.2563)


   

Octadecyl pentyl sulite

Octadecyl pentyl sulite

C23H48O3S (404.3324)


   

Methyl 3alpha-hydroxy-12-oxo-5beta-cholan-24-oate (11,11-D2)

Methyl 3alpha-hydroxy-12-oxo-5beta-cholan-24-oate (11,11-D2)

C25H40O4 (404.2926)


   

2,3-dihydroxypropyl (7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoate

2,3-dihydroxypropyl (7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoate

C25H40O4 (404.2926)


   

Lovastatin (Mevacor)

Lovastatin (Mevacor)

C24H36O5 (404.2563)


   

[1-hydroxy-3-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoxy]propan-2-yl] acetate

[1-hydroxy-3-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoxy]propan-2-yl] acetate

C25H40O4 (404.2926)


   

[1-hydroxy-3-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoxy]propan-2-yl] butanoate

[1-hydroxy-3-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoxy]propan-2-yl] butanoate

C25H40O4 (404.2926)


   

(1-hydroxy-3-propanoyloxypropan-2-yl) (3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoate

(1-hydroxy-3-propanoyloxypropan-2-yl) (3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoate

C24H36O5 (404.2563)


   

Fahfa 22:4/3:0

Fahfa 22:4/3:0

C25H40O4 (404.2926)


   

Fahfa 20:4/5:0

Fahfa 20:4/5:0

C25H40O4 (404.2926)


   

Fahfa 16:4/9:0

Fahfa 16:4/9:0

C25H40O4 (404.2926)


   

Fahfa 5:0/20:4

Fahfa 5:0/20:4

C25H40O4 (404.2926)


   

Fahfa 3:0/22:4

Fahfa 3:0/22:4

C25H40O4 (404.2926)


   

Fahfa 18:4/7:0

Fahfa 18:4/7:0

C25H40O4 (404.2926)


   

methyl (4R)-4-[(3R,5R,8R,9S,10S,13R,14S,17R)-11,11-dideuterio-3-hydroxy-10,13-dimethyl-12-oxo-2,3,4,5,6,7,8,9,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoate

methyl (4R)-4-[(3R,5R,8R,9S,10S,13R,14S,17R)-11,11-dideuterio-3-hydroxy-10,13-dimethyl-12-oxo-2,3,4,5,6,7,8,9,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoate

C25H40O4 (404.2926)


   

14-(2-(Tert-butyldimethylsiloxy)ethyl)-6,10,14-trimethylcyclotetradeca-2(E),6(E),10(E)-trienone

14-(2-(Tert-butyldimethylsiloxy)ethyl)-6,10,14-trimethylcyclotetradeca-2(E),6(E),10(E)-trienone

C25H44O2Si (404.311)


   

[(2S)-2,3-dihydroxypropyl] (7E,10E,13E,16E,19E)-docosa-7,10,13,16,19-pentaenoate

[(2S)-2,3-dihydroxypropyl] (7E,10E,13E,16E,19E)-docosa-7,10,13,16,19-pentaenoate

C25H40O4 (404.2926)


   

[1-Carboxy-3-(2-hydroxy-3-undecanoyloxypropoxy)propyl]-trimethylazanium

[1-Carboxy-3-(2-hydroxy-3-undecanoyloxypropoxy)propyl]-trimethylazanium

C21H42NO6+ (404.3012)


   

[(2S)-2,3-dihydroxypropyl] (4E,7E,10E,13E,16E)-docosa-4,7,10,13,16-pentaenoate

[(2S)-2,3-dihydroxypropyl] (4E,7E,10E,13E,16E)-docosa-4,7,10,13,16-pentaenoate

C25H40O4 (404.2926)


   

[3-(3-Acetyloxy-2-octanoyloxypropoxy)-1-carboxypropyl]-trimethylazanium

[3-(3-Acetyloxy-2-octanoyloxypropoxy)-1-carboxypropyl]-trimethylazanium

C20H38NO7+ (404.2648)


   

[1-Carboxy-3-[2,3-di(pentanoyloxy)propoxy]propyl]-trimethylazanium

[1-Carboxy-3-[2,3-di(pentanoyloxy)propoxy]propyl]-trimethylazanium

C20H38NO7+ (404.2648)


   

[1-Carboxy-3-(2-heptanoyloxy-3-propanoyloxypropoxy)propyl]-trimethylazanium

[1-Carboxy-3-(2-heptanoyloxy-3-propanoyloxypropoxy)propyl]-trimethylazanium

C20H38NO7+ (404.2648)


   

[3-(3-Butanoyloxy-2-hexanoyloxypropoxy)-1-carboxypropyl]-trimethylazanium

[3-(3-Butanoyloxy-2-hexanoyloxypropoxy)-1-carboxypropyl]-trimethylazanium

C20H38NO7+ (404.2648)


   

7alpha,12alpha-Dihydroxy-3-oxochol-4-enoate

7alpha,12alpha-Dihydroxy-3-oxochol-4-enoate

C24H36O5 (404.2563)


   

3beta-Hydroxy-7,12-dioxo-5beta-cholan-24-oic Acid

3beta-Hydroxy-7,12-dioxo-5beta-cholan-24-oic Acid

C24H36O5 (404.2563)


   

MG(0:0/22:5(7Z,10Z,13Z,16Z,19Z)/0:0)

MG(0:0/22:5(7Z,10Z,13Z,16Z,19Z)/0:0)

C25H40O4 (404.2926)


   

MG(0:0/22:5(4Z,7Z,10Z,13Z,16Z)/0:0)

MG(0:0/22:5(4Z,7Z,10Z,13Z,16Z)/0:0)

C25H40O4 (404.2926)


   

MG(22:5(4Z,7Z,10Z,13Z,16Z)/0:0/0:0)

MG(22:5(4Z,7Z,10Z,13Z,16Z)/0:0/0:0)

C25H40O4 (404.2926)


   

MG(22:5(7Z,10Z,13Z,16Z,19Z)/0:0/0:0)

MG(22:5(7Z,10Z,13Z,16Z,19Z)/0:0/0:0)

C25H40O4 (404.2926)


   

3beta,7beta,15alpha-Trihydroxy-4,4,14alpha-trimethyl-11,20-dioxo-5alpha-pregn-8-ene

3beta,7beta,15alpha-Trihydroxy-4,4,14alpha-trimethyl-11,20-dioxo-5alpha-pregn-8-ene

C24H36O5 (404.2563)


   

11-Carboxy-gamma-chromanol

11-Carboxy-gamma-chromanol

C25H40O4 (404.2926)


   

7beta-Hydroxy-3,12-dioxo-5beta-cholan-24-oic Acid

7beta-Hydroxy-3,12-dioxo-5beta-cholan-24-oic Acid

C24H36O5 (404.2563)


   

7alpha-Hydroxy-3,12-dioxo-5beta-cholan-24-oic Acid

7alpha-Hydroxy-3,12-dioxo-5beta-cholan-24-oic Acid

C24H36O5 (404.2563)


   

12alpha-Hydroxy-3,7-dioxo-5beta-cholan-24-oic Acid

12alpha-Hydroxy-3,7-dioxo-5beta-cholan-24-oic Acid

C24H36O5 (404.2563)


   

Dihomolithocholic acid

Dihomolithocholic acid

C26H44O3 (404.329)


   

3alpha-Hydroxy-1,7-dioxo-5beta-cholan-24-oic Acid

3alpha-Hydroxy-1,7-dioxo-5beta-cholan-24-oic Acid

C24H36O5 (404.2563)


   

(5Z,7E)-(1S,3R)-21-nor-20-oxa-9,10-seco-5,7,10(19)-cholestatriene-1,3,25-triol

(5Z,7E)-(1S,3R)-21-nor-20-oxa-9,10-seco-5,7,10(19)-cholestatriene-1,3,25-triol

C25H40O4 (404.2926)


   

6beta,12alpha-Dihydroxy-3-oxochol-4-en-24-oic Acid

6beta,12alpha-Dihydroxy-3-oxochol-4-en-24-oic Acid

C24H36O5 (404.2563)


   

3alpha-Hydroxy-11,12-dioxo-5beta-cholan-24-oic Acid

3alpha-Hydroxy-11,12-dioxo-5beta-cholan-24-oic Acid

C24H36O5 (404.2563)


   

2beta,3beta-Dihydroxy-6-oxo-5alpha-chol-7-en-24-oic Acid

2beta,3beta-Dihydroxy-6-oxo-5alpha-chol-7-en-24-oic Acid

C24H36O5 (404.2563)


   

3alpha,12alpha-Dihydroxy-6-oxo-5beta-chol-7-en-24-oic Acid

3alpha,12alpha-Dihydroxy-6-oxo-5beta-chol-7-en-24-oic Acid

C24H36O5 (404.2563)


   

3alpha,11-Dihydroxy-12-oxo-5beta-chol-9(11)-en-24-oic Acid

3alpha,11-Dihydroxy-12-oxo-5beta-chol-9(11)-en-24-oic Acid

C24H36O5 (404.2563)


   

3alpha,12alpha-Dihydroxy-15-oxo-5beta-chol-8(14)-en-24-oic Acid

3alpha,12alpha-Dihydroxy-15-oxo-5beta-chol-8(14)-en-24-oic Acid

C24H36O5 (404.2563)


   

yanuthone M

yanuthone M

C24H36O5 (404.2563)


A class I yanuthone that is yanuthone K in which the double bond at the terminal end of the farnesyl substituent has undergone hydration to afford the corresponding tertiary alcohol. Isolated from the filamentous fungus Aspergillus niger, it shows antifungal activity towards the pathogenic yeast Candida albicans (IC50 = 77.5 +-3.7 muM).

   

7,12-dioxolithocholic acid

7,12-dioxolithocholic acid

C24H36O5 (404.2563)


A bile acid that is lithocholic acid carrying two additional oxo substituents at positions 7 and 12.

   

DG(22:5)

DG(12:1(1)_10:4)

C25H40O4 (404.2926)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

Hydroxyhexacosatetraenoic acid

Hydroxyhexacosatetraenoic acid

C26H44O3 (404.329)


   

NA-Gln 18:4(6Z,9Z,12Z,15Z)

NA-Gln 18:4(6Z,9Z,12Z,15Z)

C23H36N2O4 (404.2675)


   

NA-Lys 18:4(6Z,9Z,12Z,15Z)

NA-Lys 18:4(6Z,9Z,12Z,15Z)

C24H40N2O3 (404.3039)


   

FAHFA 10:0/O-15:4

FAHFA 10:0/O-15:4

C25H40O4 (404.2926)


   

FAHFA 10:1/O-15:3

FAHFA 10:1/O-15:3

C25H40O4 (404.2926)


   

FAHFA 10:2/O-15:2

FAHFA 10:2/O-15:2

C25H40O4 (404.2926)


   

FAHFA 10:3/O-15:1

FAHFA 10:3/O-15:1

C25H40O4 (404.2926)


   

FAHFA 11:0/O-14:4

FAHFA 11:0/O-14:4

C25H40O4 (404.2926)


   

FAHFA 11:1/O-14:3

FAHFA 11:1/O-14:3

C25H40O4 (404.2926)


   

FAHFA 11:2/O-14:2

FAHFA 11:2/O-14:2

C25H40O4 (404.2926)


   

FAHFA 11:3/O-14:1

FAHFA 11:3/O-14:1

C25H40O4 (404.2926)


   

FAHFA 12:0/O-13:4

FAHFA 12:0/O-13:4

C25H40O4 (404.2926)


   

FAHFA 12:1/O-13:3

FAHFA 12:1/O-13:3

C25H40O4 (404.2926)


   

FAHFA 12:2/O-13:2

FAHFA 12:2/O-13:2

C25H40O4 (404.2926)


   

FAHFA 12:3/O-13:1

FAHFA 12:3/O-13:1

C25H40O4 (404.2926)


   

FAHFA 12:4/O-13:0

FAHFA 12:4/O-13:0

C25H40O4 (404.2926)


   

FAHFA 13:0/O-12:4

FAHFA 13:0/O-12:4

C25H40O4 (404.2926)


   

FAHFA 13:1/O-12:3

FAHFA 13:1/O-12:3

C25H40O4 (404.2926)


   

FAHFA 13:2/O-12:2

FAHFA 13:2/O-12:2

C25H40O4 (404.2926)


   

FAHFA 13:3/O-12:1

FAHFA 13:3/O-12:1

C25H40O4 (404.2926)


   

FAHFA 13:4/O-12:0

FAHFA 13:4/O-12:0

C25H40O4 (404.2926)


   

FAHFA 14:1/O-11:3

FAHFA 14:1/O-11:3

C25H40O4 (404.2926)


   

FAHFA 14:2/O-11:2

FAHFA 14:2/O-11:2

C25H40O4 (404.2926)


   

FAHFA 14:3/O-11:1

FAHFA 14:3/O-11:1

C25H40O4 (404.2926)


   

FAHFA 14:4/O-11:0

FAHFA 14:4/O-11:0

C25H40O4 (404.2926)


   

FAHFA 15:1/O-10:3

FAHFA 15:1/O-10:3

C25H40O4 (404.2926)


   

FAHFA 15:2/O-10:2

FAHFA 15:2/O-10:2

C25H40O4 (404.2926)


   

FAHFA 15:3/O-10:1

FAHFA 15:3/O-10:1

C25H40O4 (404.2926)


   

FAHFA 15:4/O-10:0

FAHFA 15:4/O-10:0

C25H40O4 (404.2926)


   

FAHFA 16:1/O-9:3

FAHFA 16:1/O-9:3

C25H40O4 (404.2926)


   

FAHFA 16:2/O-9:2

FAHFA 16:2/O-9:2

C25H40O4 (404.2926)


   

FAHFA 16:3/O-9:1

FAHFA 16:3/O-9:1

C25H40O4 (404.2926)


   

FAHFA 16:4/O-9:0

FAHFA 16:4/O-9:0

C25H40O4 (404.2926)


   

FAHFA 17:2/O-8:2

FAHFA 17:2/O-8:2

C25H40O4 (404.2926)


   

FAHFA 17:3/O-8:1

FAHFA 17:3/O-8:1

C25H40O4 (404.2926)


   

FAHFA 17:4/O-8:0

FAHFA 17:4/O-8:0

C25H40O4 (404.2926)


   

FAHFA 25:4;O

FAHFA 25:4;O

C25H40O4 (404.2926)


   

FAHFA 8:0/O-17:4

FAHFA 8:0/O-17:4

C25H40O4 (404.2926)


   

FAHFA 8:1/O-17:3

FAHFA 8:1/O-17:3

C25H40O4 (404.2926)


   

FAHFA 8:2/O-17:2

FAHFA 8:2/O-17:2

C25H40O4 (404.2926)


   

FAHFA 9:0/O-16:4

FAHFA 9:0/O-16:4

C25H40O4 (404.2926)


   

FAHFA 9:1/O-16:3

FAHFA 9:1/O-16:3

C25H40O4 (404.2926)


   

FAHFA 9:2/O-16:2

FAHFA 9:2/O-16:2

C25H40O4 (404.2926)


   

FAHFA 9:3/O-16:1

FAHFA 9:3/O-16:1

C25H40O4 (404.2926)


   

7,12-Diketolithocholic acid

7,12-Diketolithocholic acid

C24H36O5 (404.2563)


   

Dihydroxyoxocholenoic acid

Dihydroxyoxocholenoic acid

C24H36O5 (404.2563)


   

Diketolithocholic acid

Diketolithocholic acid

C24H36O5 (404.2563)


   
   

ST 29:6;O

ST 29:6;O

C29H40O (404.3079)


   

TBPB

TBPB

C25H32N4O (404.2576)


TBPB is an allosteric M1 mAChR agonist(EC50=289 nM) that regulates amyloid processing and produces antipsychotic-like activity in rats. IC50 value: 289 nM(EC50) [2] Target: M1 mAChR agonist in vitro: TBPB activates M(1) through an allosteric site rather than the orthosteric acetylcholine binding site, which is likely critical for its unprecedented selectivity. Whole-cell patch-clamp recordings demonstrated that activation of M(1) by TBPB potentiates NMDA receptor currents in hippocampal pyramidal cells but does not alter excitatory or inhibitory synaptic transmission, responses thought to be mediated by M(2) and M(4) [1]. in vivo: TBPB was efficacious in models predictive of antipsychotic-like activity in rats at doses that did not produce catalepsy or peripheral adverse effects of other mAChR agonists [1].

   

(1s,3s,3ar,4s,5ar,7s,9as,11ar)-1-acetyl-3,4,7-trihydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-10-one

(1s,3s,3ar,4s,5ar,7s,9as,11ar)-1-acetyl-3,4,7-trihydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-10-one

C24H36O5 (404.2563)


   

5-(5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl)-3-{[(2-methylbutanoyl)oxy]methyl}pent-2-enoic acid

5-(5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl)-3-{[(2-methylbutanoyl)oxy]methyl}pent-2-enoic acid

C25H40O4 (404.2926)


   

(1s,2s,4s,9s,10r)-14-oxo-7,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadecan-4-yl (3r,5e)-3-hydroxyoct-5-enoate

(1s,2s,4s,9s,10r)-14-oxo-7,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadecan-4-yl (3r,5e)-3-hydroxyoct-5-enoate

C23H36N2O4 (404.2675)


   

[(1r,4r,8s,9r,10r,12r,13s)-8-(acetyloxy)-12-hydroxy-5,5,9-trimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadec-14-en-13-yl]methyl acetate

[(1r,4r,8s,9r,10r,12r,13s)-8-(acetyloxy)-12-hydroxy-5,5,9-trimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadec-14-en-13-yl]methyl acetate

C24H36O5 (404.2563)


   

9a,11a-dimethyl-1-(5-methylhex-3-en-2-yl)-tetradecahydrocyclopenta[a]phenanthrene-5,5a,7-triol

9a,11a-dimethyl-1-(5-methylhex-3-en-2-yl)-tetradecahydrocyclopenta[a]phenanthrene-5,5a,7-triol

C26H44O3 (404.329)


   

(1s,4s,5r,9s,10r,13r,14s)-5,9-dimethyl-14-{[(3-methylbutanoyl)oxy]methyl}tetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylic acid

(1s,4s,5r,9s,10r,13r,14s)-5,9-dimethyl-14-{[(3-methylbutanoyl)oxy]methyl}tetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylic acid

C25H40O4 (404.2926)


   

(3r)-5-[(1r,4ar,7s,8as)-2,5,5,8a-tetramethyl-7-{[(2z)-2-methylbut-2-enoyl]oxy}-1,4,4a,6,7,8-hexahydronaphthalen-1-yl]-3-methylpentanoic acid

(3r)-5-[(1r,4ar,7s,8as)-2,5,5,8a-tetramethyl-7-{[(2z)-2-methylbut-2-enoyl]oxy}-1,4,4a,6,7,8-hexahydronaphthalen-1-yl]-3-methylpentanoic acid

C25H40O4 (404.2926)


   

(3r,4s)-1,4-dimethyl-4-[(1e)-4-[(1r)-4-methylcyclohex-3-en-1-yl]penta-1,3-dien-1-yl]-3-{2-[(1r)-4-methylcyclohex-3-en-1-yl]prop-1-en-1-yl}cyclohex-1-ene

(3r,4s)-1,4-dimethyl-4-[(1e)-4-[(1r)-4-methylcyclohex-3-en-1-yl]penta-1,3-dien-1-yl]-3-{2-[(1r)-4-methylcyclohex-3-en-1-yl]prop-1-en-1-yl}cyclohex-1-ene

C30H44 (404.3443)


   

(1r,2e,4z,7r,8e,12e,14r)-14-(acetyloxy)-7-hydroxy-2-isopropyl-5,9,13-trimethylcyclotetradeca-2,4,8,12-tetraen-1-yl acetate

(1r,2e,4z,7r,8e,12e,14r)-14-(acetyloxy)-7-hydroxy-2-isopropyl-5,9,13-trimethylcyclotetradeca-2,4,8,12-tetraen-1-yl acetate

C24H36O5 (404.2563)


   

(1r,4s,5s,6r,9s,10s,13r,16s)-6-(acetyloxy)-5-(hydroxymethyl)-5,9,13-trimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadec-14-en-16-yl acetate

(1r,4s,5s,6r,9s,10s,13r,16s)-6-(acetyloxy)-5-(hydroxymethyl)-5,9,13-trimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadec-14-en-16-yl acetate

C24H36O5 (404.2563)


   

2,3-dihydroxypropyl 8,11,12-trihydroxyoctadec-9-enoate

2,3-dihydroxypropyl 8,11,12-trihydroxyoctadec-9-enoate

C21H40O7 (404.2774)


   

(4r)-5-{[(2e)-5-[(1r,4as,6s,8ar)-6-hydroxy-2,5,5,8a-tetramethyl-1,4,4a,6,7,8-hexahydronaphthalen-1-yl]-3-methylpent-2-en-1-yl]oxy}-4-methylpentan-2-one

(4r)-5-{[(2e)-5-[(1r,4as,6s,8ar)-6-hydroxy-2,5,5,8a-tetramethyl-1,4,4a,6,7,8-hexahydronaphthalen-1-yl]-3-methylpent-2-en-1-yl]oxy}-4-methylpentan-2-one

C26H44O3 (404.329)


   

4,8,11,15-tetramethyl-9-oxo-10,18-dioxatetracyclo[9.7.0.0²,⁷.0³,¹⁷]octadec-14-en-4-yl butanoate

4,8,11,15-tetramethyl-9-oxo-10,18-dioxatetracyclo[9.7.0.0²,⁷.0³,¹⁷]octadec-14-en-4-yl butanoate

C24H36O5 (404.2563)


   

2-(acetyloxy)-4,9,12-trimethyl-15-(prop-1-en-2-yl)-5-oxatricyclo[10.3.0.0⁴,⁶]pentadec-9-en-11-yl acetate

2-(acetyloxy)-4,9,12-trimethyl-15-(prop-1-en-2-yl)-5-oxatricyclo[10.3.0.0⁴,⁶]pentadec-9-en-11-yl acetate

C24H36O5 (404.2563)


   

(1r,2s,3r,4r,7s,8r,11r,14e,17r)-4,8,11,15-tetramethyl-9-oxo-10,18-dioxatetracyclo[9.7.0.0²,⁷.0³,¹⁷]octadec-14-en-4-yl butanoate

(1r,2s,3r,4r,7s,8r,11r,14e,17r)-4,8,11,15-tetramethyl-9-oxo-10,18-dioxatetracyclo[9.7.0.0²,⁷.0³,¹⁷]octadec-14-en-4-yl butanoate

C24H36O5 (404.2563)


   

10-hydroxy-3,7,11-trimethylhexadecyl benzoate

10-hydroxy-3,7,11-trimethylhexadecyl benzoate

C26H44O3 (404.329)


   

[7-(acetyloxy)-7-isopropyl-1,4a-dimethyl-9-oxo-2,3,4,4b,5,6,10,10a-octahydrophenanthren-1-yl]methyl acetate

[7-(acetyloxy)-7-isopropyl-1,4a-dimethyl-9-oxo-2,3,4,4b,5,6,10,10a-octahydrophenanthren-1-yl]methyl acetate

C24H36O5 (404.2563)


   

4-hydroxy-2-methyl-3,6-dioxo-5-(pentadec-10-en-1-yl)cyclohexa-1,4-dien-1-yl acetate

4-hydroxy-2-methyl-3,6-dioxo-5-(pentadec-10-en-1-yl)cyclohexa-1,4-dien-1-yl acetate

C24H36O5 (404.2563)


   

(4r)-4-[(9as,11s,11ar)-11-hydroxy-9a,11a-dimethyl-4,7-dioxo-dodecahydro-1h-cyclopenta[a]phenanthren-1-yl]pentanoic acid

(4r)-4-[(9as,11s,11ar)-11-hydroxy-9a,11a-dimethyl-4,7-dioxo-dodecahydro-1h-cyclopenta[a]phenanthren-1-yl]pentanoic acid

C24H36O5 (404.2563)


   

[(1s,4s,6r,9s,10s,13r,14r)-6,14-dihydroxy-5,5,9-trimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-14-yl]methyl (2z)-2-methylbut-2-enoate

[(1s,4s,6r,9s,10s,13r,14r)-6,14-dihydroxy-5,5,9-trimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-14-yl]methyl (2z)-2-methylbut-2-enoate

C25H40O4 (404.2926)


   

5-{2,5,5,8a-tetramethyl-7-[(2-methylbut-2-enoyl)oxy]-1,4,4a,6,7,8-hexahydronaphthalen-1-yl}-3-methylpentanoic acid

5-{2,5,5,8a-tetramethyl-7-[(2-methylbut-2-enoyl)oxy]-1,4,4a,6,7,8-hexahydronaphthalen-1-yl}-3-methylpentanoic acid

C25H40O4 (404.2926)


   

methyl 2-{6-methyl-6-[2-(1,1,3,6-tetramethyl-4a,7,8,8a-tetrahydro-4h-naphthalen-2-yl)ethyl]-1,2-dioxan-3-yl}propanoate

methyl 2-{6-methyl-6-[2-(1,1,3,6-tetramethyl-4a,7,8,8a-tetrahydro-4h-naphthalen-2-yl)ethyl]-1,2-dioxan-3-yl}propanoate

C25H40O4 (404.2926)


   

(1s,2s,5s,9s,10s,11s,12r,13s,14s,16r,17s)-16-[(2s)-1,2-dihydroxypropan-2-yl]-5,9,10,13-tetramethylhexacyclo[9.7.0.0²,⁶.0²,⁹.0¹²,¹⁷.0¹³,¹⁷]octadecane-5,14-diol

(1s,2s,5s,9s,10s,11s,12r,13s,14s,16r,17s)-16-[(2s)-1,2-dihydroxypropan-2-yl]-5,9,10,13-tetramethylhexacyclo[9.7.0.0²,⁶.0²,⁹.0¹²,¹⁷.0¹³,¹⁷]octadecane-5,14-diol

C25H40O4 (404.2926)


   

(1r,2r,3r,4s,7r,8r,10z,14r)-14-(acetyloxy)-3-isopropyl-6,10,14-trimethyl-15-oxatricyclo[6.6.1.0²,⁷]pentadeca-5,10-dien-4-yl acetate

(1r,2r,3r,4s,7r,8r,10z,14r)-14-(acetyloxy)-3-isopropyl-6,10,14-trimethyl-15-oxatricyclo[6.6.1.0²,⁷]pentadeca-5,10-dien-4-yl acetate

C24H36O5 (404.2563)


   

6-(11-hydroxy-3,7,11-trimethyldodeca-2,6-dien-1-yl)-3-methyl-5-oxo-7-oxabicyclo[4.1.0]hept-3-en-2-yl acetate

6-(11-hydroxy-3,7,11-trimethyldodeca-2,6-dien-1-yl)-3-methyl-5-oxo-7-oxabicyclo[4.1.0]hept-3-en-2-yl acetate

C24H36O5 (404.2563)


   

2,4-dihydroxy-1-{4-hydroxy-3,6,7a,10-tetramethyl-1h,2h,3h,4h,5h,6h,8h,9h,10ah,10bh-cyclopenta[d]s-indacen-10-yl}-4-methylpentan-3-one

2,4-dihydroxy-1-{4-hydroxy-3,6,7a,10-tetramethyl-1h,2h,3h,4h,5h,6h,8h,9h,10ah,10bh-cyclopenta[d]s-indacen-10-yl}-4-methylpentan-3-one

C25H40O4 (404.2926)


   

16-(dimethylamino)-6,7,13,17-tetramethyl-7-azapentacyclo[10.8.0.0²,⁹.0⁵,⁹.0¹³,¹⁸]icosane-18,20-diol

16-(dimethylamino)-6,7,13,17-tetramethyl-7-azapentacyclo[10.8.0.0²,⁹.0⁵,⁹.0¹³,¹⁸]icosane-18,20-diol

C25H44N2O2 (404.3403)


   

(1'r,2s,3s,3'r,5r,7'r,9'e,11's,12'r,14'r)-10'-(hydroxymethyl)-3,3',14'-trimethyl-5-(2-methylprop-1-en-1-yl)spiro[oxolane-2,6'-tricyclo[9.3.0.0³,⁷]tetradecan]-9'-ene-1',12'-diol

(1'r,2s,3s,3'r,5r,7'r,9'e,11's,12'r,14'r)-10'-(hydroxymethyl)-3,3',14'-trimethyl-5-(2-methylprop-1-en-1-yl)spiro[oxolane-2,6'-tricyclo[9.3.0.0³,⁷]tetradecan]-9'-ene-1',12'-diol

C25H40O4 (404.2926)


   

4-hydroxy-5-methyl-3,6-dioxo-2-[(10z)-pentadec-10-en-1-yl]cyclohexa-1,4-dien-1-yl acetate

4-hydroxy-5-methyl-3,6-dioxo-2-[(10z)-pentadec-10-en-1-yl]cyclohexa-1,4-dien-1-yl acetate

C24H36O5 (404.2563)


   

4-[2-(1,2,4a-trimethyl-5-methylidene-hexahydro-2h-naphthalen-1-yl)ethylidene]-5-(acetyloxy)oxolan-2-yl acetate

4-[2-(1,2,4a-trimethyl-5-methylidene-hexahydro-2h-naphthalen-1-yl)ethylidene]-5-(acetyloxy)oxolan-2-yl acetate

C24H36O5 (404.2563)


   

3-hydroxy-4,6b,8a,12b,14a-pentamethyl-11-methylidene-7,8,9,10,12,12a,13,14-octahydropicen-2-one

3-hydroxy-4,6b,8a,12b,14a-pentamethyl-11-methylidene-7,8,9,10,12,12a,13,14-octahydropicen-2-one

C28H36O2 (404.2715)


   

(3s)-5-[(1s,4ar,5s,8ar)-2,5,8a-trimethyl-5-({[(2z)-2-methylbut-2-enoyl]oxy}methyl)-1,4,4a,6,7,8-hexahydronaphthalen-1-yl]-3-methylpentanoic acid

(3s)-5-[(1s,4ar,5s,8ar)-2,5,8a-trimethyl-5-({[(2z)-2-methylbut-2-enoyl]oxy}methyl)-1,4,4a,6,7,8-hexahydronaphthalen-1-yl]-3-methylpentanoic acid

C25H40O4 (404.2926)


   

1-(4-Ethoxy-2hydroxyphenyl)-1-octadecanone

NA

C26H44O3 (404.329)


{"Ingredient_id": "HBIN001456","Ingredient_name": "1-(4-Ethoxy-2hydroxyphenyl)-1-octadecanone","Alias": "NA","Ingredient_formula": "C26H44O3","Ingredient_Smile": "CCCCCCCCCCCCCCCCCC(=O)C1=C(C=C(C=C1)OCC)O","Ingredient_weight": "404.6 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "40268","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "601846","DrugBank_id": "NA"}

   

16αh,17-isovalerate-ent-kauran-19-oicacid

NA

C25H40O4 (404.2926)


{"Ingredient_id": "HBIN001802","Ingredient_name": "16\u03b1h,17-isovalerate-ent-kauran-19-oicacid","Alias": "NA","Ingredient_formula": "C25H40O4","Ingredient_Smile": "CC(C)CC(=O)OCC1CC23CCC4C(C2CCC1C3)(CCCC4(C)C(=O)O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "11750","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

2,5-dihydroxy-3-(nonadec-14-enyl)-benzo-quinone

NA

C25H40O4 (404.2926)


{"Ingredient_id": "HBIN004620","Ingredient_name": "2,5-dihydroxy-3-(nonadec-14-enyl)-benzo-quinone","Alias": "NA","Ingredient_formula": "C25H40O4","Ingredient_Smile": "CCCCC=CCCCCCCCCCCCCCC1=C(C(=O)C=C(C1=O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "6047","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

[(1r,2s,4s,5s,9r,10s,13s,14r)-2-(acetyloxy)-14-hydroxy-5,9,14-trimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadec-11-en-5-yl]methyl acetate

[(1r,2s,4s,5s,9r,10s,13s,14r)-2-(acetyloxy)-14-hydroxy-5,9,14-trimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadec-11-en-5-yl]methyl acetate

C24H36O5 (404.2563)


   

(2s,3s)-2-[(3as,4r,5s,7r,8ar)-7-(acetyloxy)-4-hydroxy-3-methyl-8-methylidene-3a,4,5,6,7,8a-hexahydro-1h-azulen-5-yl]-6-methylhept-5-en-3-yl acetate

(2s,3s)-2-[(3as,4r,5s,7r,8ar)-7-(acetyloxy)-4-hydroxy-3-methyl-8-methylidene-3a,4,5,6,7,8a-hexahydro-1h-azulen-5-yl]-6-methylhept-5-en-3-yl acetate

C24H36O5 (404.2563)


   

4-({6-hydroxy-5,9-dimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-5-yl}methoxy)-4-oxobutanoic acid

4-({6-hydroxy-5,9-dimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-5-yl}methoxy)-4-oxobutanoic acid

C24H36O5 (404.2563)


   

3-(15-hydroxyicosa-11,13-diyn-1-yl)-5-(hydroxymethyl)oxolan-2-one

3-(15-hydroxyicosa-11,13-diyn-1-yl)-5-(hydroxymethyl)oxolan-2-one

C25H40O4 (404.2926)


   

{2-[(5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl)methyl]-5-isopropoxyoxolan-3-ylidene}methyl acetate

{2-[(5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl)methyl]-5-isopropoxyoxolan-3-ylidene}methyl acetate

C25H40O4 (404.2926)


   

(2s,3s,4ar,5r,8as)-3-hydroxy-5-[(3e)-5-hydroxy-3-methylpent-3-en-1-yl]-1,1,4a,6-tetramethyl-2,3,4,5,8,8a-hexahydronaphthalen-2-yl (2z)-2-methylbut-2-enoate

(2s,3s,4ar,5r,8as)-3-hydroxy-5-[(3e)-5-hydroxy-3-methylpent-3-en-1-yl]-1,1,4a,6-tetramethyl-2,3,4,5,8,8a-hexahydronaphthalen-2-yl (2z)-2-methylbut-2-enoate

C25H40O4 (404.2926)


   

2-methoxy-6-nonadecylcyclohexa-2,5-diene-1,4-dione

2-methoxy-6-nonadecylcyclohexa-2,5-diene-1,4-dione

C26H44O3 (404.329)


   

(6bs,8ar,12ar,12bs,14ar)-3-hydroxy-4,6b,8a,12b,14a-pentamethyl-11-methylidene-7,8,9,10,12,12a,13,14-octahydropicen-2-one

(6bs,8ar,12ar,12bs,14ar)-3-hydroxy-4,6b,8a,12b,14a-pentamethyl-11-methylidene-7,8,9,10,12,12a,13,14-octahydropicen-2-one

C28H36O2 (404.2715)


   

(1s,2s,3r,4z,6z,10z,14s)-2-(acetyloxy)-4-isopropyl-1,7,11-trimethyl-15-oxabicyclo[12.1.0]pentadeca-4,6,10-trien-3-yl acetate

(1s,2s,3r,4z,6z,10z,14s)-2-(acetyloxy)-4-isopropyl-1,7,11-trimethyl-15-oxabicyclo[12.1.0]pentadeca-4,6,10-trien-3-yl acetate

C24H36O5 (404.2563)


   

2,6,6-trimethyl-3-[(3r)-2,6,6-trimethylbicyclo[3.1.1]hept-1-en-3-yl]-3-{2,6,6-trimethylbicyclo[3.1.1]hept-1-en-3-yl}bicyclo[3.1.1]hept-1-ene

2,6,6-trimethyl-3-[(3r)-2,6,6-trimethylbicyclo[3.1.1]hept-1-en-3-yl]-3-{2,6,6-trimethylbicyclo[3.1.1]hept-1-en-3-yl}bicyclo[3.1.1]hept-1-ene

C30H44 (404.3443)


   

5-(acetyloxy)-5-{4,12-dimethyl-9-methylidene-5-oxatricyclo[8.2.0.0⁴,⁶]dodecan-12-yl}-2-methylpent-2-en-1-yl acetate

5-(acetyloxy)-5-{4,12-dimethyl-9-methylidene-5-oxatricyclo[8.2.0.0⁴,⁶]dodecan-12-yl}-2-methylpent-2-en-1-yl acetate

C24H36O5 (404.2563)


   

(1s,2s,3r,4r,7r,8r,11s,14z,17s)-4,8,11,15-tetramethyl-9-oxo-10,18-dioxatetracyclo[9.7.0.0²,⁷.0³,¹⁷]octadec-14-en-4-yl butanoate

(1s,2s,3r,4r,7r,8r,11s,14z,17s)-4,8,11,15-tetramethyl-9-oxo-10,18-dioxatetracyclo[9.7.0.0²,⁷.0³,¹⁷]octadec-14-en-4-yl butanoate

C24H36O5 (404.2563)


   

(1r,3as,3bs,5as,9as,9bs,10r,11ar)-1-ethenyl-7,7-dimethoxy-9a,11a-dimethyl-tetradecahydrocyclopenta[a]phenanthren-10-yl acetate

(1r,3as,3bs,5as,9as,9bs,10r,11ar)-1-ethenyl-7,7-dimethoxy-9a,11a-dimethyl-tetradecahydrocyclopenta[a]phenanthren-10-yl acetate

C25H40O4 (404.2926)


   

[(1s,4s,4ar,8as)-4-(acetyloxy)-1-[(1e,3s)-3-hydroxy-3-methylpenta-1,4-dien-1-yl]-5,5,8a-trimethyl-1,4,4a,6,7,8-hexahydronaphthalen-2-yl]methyl acetate

[(1s,4s,4ar,8as)-4-(acetyloxy)-1-[(1e,3s)-3-hydroxy-3-methylpenta-1,4-dien-1-yl]-5,5,8a-trimethyl-1,4,4a,6,7,8-hexahydronaphthalen-2-yl]methyl acetate

C24H36O5 (404.2563)


   

[(2s,3e,5r)-2-{[(1r,4ar,8ar)-5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]methyl}-5-isopropoxyoxolan-3-ylidene]methyl acetate

[(2s,3e,5r)-2-{[(1r,4ar,8ar)-5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]methyl}-5-isopropoxyoxolan-3-ylidene]methyl acetate

C25H40O4 (404.2926)


   

4-[(1r,3as,3br,5as,7r,9ar,9bs,11ar)-3a,5a,7-trihydroxy-7,9a,11a-trimethyl-dodecahydrocyclopenta[a]phenanthren-1-yl]-5h-furan-2-one

4-[(1r,3as,3br,5as,7r,9ar,9bs,11ar)-3a,5a,7-trihydroxy-7,9a,11a-trimethyl-dodecahydrocyclopenta[a]phenanthren-1-yl]-5h-furan-2-one

C24H36O5 (404.2563)


   

10-(acetyloxy)-4a-hydroxy-1-isopropyl-3a,8a-dimethyl-5-methylidene-2h,3h,4h,6h,7h,8h,9h,10h-cyclohexa[f]azulen-9-yl acetate

10-(acetyloxy)-4a-hydroxy-1-isopropyl-3a,8a-dimethyl-5-methylidene-2h,3h,4h,6h,7h,8h,9h,10h-cyclohexa[f]azulen-9-yl acetate

C24H36O5 (404.2563)


   

2,5-dihydroxy-3-[(14e)-nonadec-14-en-1-yl]cyclohexa-2,5-diene-1,4-dione

2,5-dihydroxy-3-[(14e)-nonadec-14-en-1-yl]cyclohexa-2,5-diene-1,4-dione

C25H40O4 (404.2926)


   

(3as,4ar,8s,8ar,9s)-8-(acetyloxy)-4a-hydroxy-1-isopropyl-3a,8a-dimethyl-5-methylidene-2h,3h,4h,6h,7h,8h,9h,10h-cyclohexa[f]azulen-9-yl acetate

(3as,4ar,8s,8ar,9s)-8-(acetyloxy)-4a-hydroxy-1-isopropyl-3a,8a-dimethyl-5-methylidene-2h,3h,4h,6h,7h,8h,9h,10h-cyclohexa[f]azulen-9-yl acetate

C24H36O5 (404.2563)


   

pentadecyl 3-(2-hydroxy-4-methoxyphenyl)prop-2-enoate

pentadecyl 3-(2-hydroxy-4-methoxyphenyl)prop-2-enoate

C25H40O4 (404.2926)


   

3-[10-(4-hydroxyphenyl)decyl]-3,4a-dimethyl-dihydro-4h-furo[3,2-c][1,2]dioxin-6-one

3-[10-(4-hydroxyphenyl)decyl]-3,4a-dimethyl-dihydro-4h-furo[3,2-c][1,2]dioxin-6-one

C24H36O5 (404.2563)


   

(2s)-1-[(3s,3ar,4r,6s,7ar,10r,10ar,10bs)-4-hydroxy-3,6,7a,10-tetramethyl-1h,2h,3h,4h,5h,6h,8h,9h,10ah,10bh-cyclopenta[d]s-indacen-10-yl]-2,4-dihydroxy-4-methylpentan-3-one

(2s)-1-[(3s,3ar,4r,6s,7ar,10r,10ar,10bs)-4-hydroxy-3,6,7a,10-tetramethyl-1h,2h,3h,4h,5h,6h,8h,9h,10ah,10bh-cyclopenta[d]s-indacen-10-yl]-2,4-dihydroxy-4-methylpentan-3-one

C25H40O4 (404.2926)


   

1,12-dihydroxy-16-isopropyl-6,10,13-trimethylpentacyclo[9.7.0.0²,⁷.0³,⁷.0¹³,¹⁷]octadecane-2-carboxylic acid

1,12-dihydroxy-16-isopropyl-6,10,13-trimethylpentacyclo[9.7.0.0²,⁷.0³,⁷.0¹³,¹⁷]octadecane-2-carboxylic acid

C25H40O4 (404.2926)


   

(3r,5r)-3-hydroxy-1-methoxy-1-oxodecan-5-yl (3r,5r)-3,5-dihydroxydecanoate

(3r,5r)-3-hydroxy-1-methoxy-1-oxodecan-5-yl (3r,5r)-3,5-dihydroxydecanoate

C21H40O7 (404.2774)


   

(1s,2s,5s,6s,9r,12s,13r,16s,17r,18r,20r)-16-(dimethylamino)-6,7,13,17-tetramethyl-7-azapentacyclo[10.8.0.0²,⁹.0⁵,⁹.0¹³,¹⁸]icosane-18,20-diol

(1s,2s,5s,6s,9r,12s,13r,16s,17r,18r,20r)-16-(dimethylamino)-6,7,13,17-tetramethyl-7-azapentacyclo[10.8.0.0²,⁹.0⁵,⁹.0¹³,¹⁸]icosane-18,20-diol

C25H44N2O2 (404.3403)


   

4-{11-hydroxy-9a,11a-dimethyl-4,7-dioxo-dodecahydro-1h-cyclopenta[a]phenanthren-1-yl}pentanoic acid

4-{11-hydroxy-9a,11a-dimethyl-4,7-dioxo-dodecahydro-1h-cyclopenta[a]phenanthren-1-yl}pentanoic acid

C24H36O5 (404.2563)


   

[(1e,3s,4r,7e,12s)-3-(acetyloxy)-12-hydroxy-7,11-dimethyl-4-(prop-1-en-2-yl)cyclotetradeca-1,7,10-trien-1-yl]methyl acetate

[(1e,3s,4r,7e,12s)-3-(acetyloxy)-12-hydroxy-7,11-dimethyl-4-(prop-1-en-2-yl)cyclotetradeca-1,7,10-trien-1-yl]methyl acetate

C24H36O5 (404.2563)


   

4-hydroxy-5-methyl-3,6-dioxo-2-(pentadec-10-en-1-yl)cyclohexa-1,4-dien-1-yl acetate

4-hydroxy-5-methyl-3,6-dioxo-2-(pentadec-10-en-1-yl)cyclohexa-1,4-dien-1-yl acetate

C24H36O5 (404.2563)


   

(2e)-4-{[(2e,6e,10e,14e)-16-hydroxy-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraen-1-yl]oxy}-4-oxobut-2-enoic acid

(2e)-4-{[(2e,6e,10e,14e)-16-hydroxy-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraen-1-yl]oxy}-4-oxobut-2-enoic acid

C24H36O5 (404.2563)


   

methyl (1s,2s,3s,6r,7s,10r,11r,12r)-2-(7-phenylheptyl)tetracyclo[8.2.1.0³,¹².0⁶,¹¹]trideca-4,8-diene-7-carboxylate

methyl (1s,2s,3s,6r,7s,10r,11r,12r)-2-(7-phenylheptyl)tetracyclo[8.2.1.0³,¹².0⁶,¹¹]trideca-4,8-diene-7-carboxylate

C28H36O2 (404.2715)


   

5-(5-hydroxy-3-methylpent-3-en-1-yl)-1-(hydroxymethyl)-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalen-2-yl 2-methylbut-2-enoate

5-(5-hydroxy-3-methylpent-3-en-1-yl)-1-(hydroxymethyl)-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalen-2-yl 2-methylbut-2-enoate

C25H40O4 (404.2926)


   

3-hydroxy-1-methoxy-1-oxodecan-5-yl 3,5-dihydroxydecanoate

3-hydroxy-1-methoxy-1-oxodecan-5-yl 3,5-dihydroxydecanoate

C21H40O7 (404.2774)


   

5-[3-(acetyloxy)-1,2,4a,5-tetramethyl-7-oxo-3,4,8,8a-tetrahydro-2h-naphthalen-1-yl]-3-methylpent-1-en-3-yl acetate

5-[3-(acetyloxy)-1,2,4a,5-tetramethyl-7-oxo-3,4,8,8a-tetrahydro-2h-naphthalen-1-yl]-3-methylpent-1-en-3-yl acetate

C24H36O5 (404.2563)


   

(1r,2r,3r,6s,7s,10s,11s,12s,13s,16r,17s)-1,12-dihydroxy-16-isopropyl-6,10,13-trimethylpentacyclo[9.7.0.0²,⁷.0³,⁷.0¹³,¹⁷]octadecane-2-carboxylic acid

(1r,2r,3r,6s,7s,10s,11s,12s,13s,16r,17s)-1,12-dihydroxy-16-isopropyl-6,10,13-trimethylpentacyclo[9.7.0.0²,⁷.0³,⁷.0¹³,¹⁷]octadecane-2-carboxylic acid

C25H40O4 (404.2926)


   

(3s,5s)-3-[(15s)-15-hydroxyicosa-11,13-diyn-1-yl]-5-(hydroxymethyl)oxolan-2-one

(3s,5s)-3-[(15s)-15-hydroxyicosa-11,13-diyn-1-yl]-5-(hydroxymethyl)oxolan-2-one

C25H40O4 (404.2926)


   

epilovastatin

epilovastatin

C24H36O5 (404.2563)


   

(1s,5r,6r)-3-(ethoxymethyl)-5-hydroxy-6-[(2e,4e,6s,7e)-6-methyldodeca-2,4,7-trien-2-yl]-4-oxocyclohex-2-en-1-yl acetate

(1s,5r,6r)-3-(ethoxymethyl)-5-hydroxy-6-[(2e,4e,6s,7e)-6-methyldodeca-2,4,7-trien-2-yl]-4-oxocyclohex-2-en-1-yl acetate

C24H36O5 (404.2563)


   

1-acetyl-3,4,7-trihydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-10-one

1-acetyl-3,4,7-trihydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-10-one

C24H36O5 (404.2563)


   

3-(acetyloxy)-4-isopropyl-1,7,11-trimethyl-15-oxabicyclo[12.1.0]pentadeca-4,6,10-trien-2-yl acetate

3-(acetyloxy)-4-isopropyl-1,7,11-trimethyl-15-oxabicyclo[12.1.0]pentadeca-4,6,10-trien-2-yl acetate

C24H36O5 (404.2563)


   

[(1r,2s,4r,5s,9r,10s,13r)-2-(acetyloxy)-5-(hydroxymethyl)-5,9-dimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadec-14-en-14-yl]methyl acetate

[(1r,2s,4r,5s,9r,10s,13r)-2-(acetyloxy)-5-(hydroxymethyl)-5,9-dimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadec-14-en-14-yl]methyl acetate

C24H36O5 (404.2563)


   

methyl 2-(7-phenylheptyl)tetracyclo[8.2.1.0³,¹².0⁶,¹¹]trideca-4,8-diene-7-carboxylate

methyl 2-(7-phenylheptyl)tetracyclo[8.2.1.0³,¹².0⁶,¹¹]trideca-4,8-diene-7-carboxylate

C28H36O2 (404.2715)


   

4-{[(2e)-5-[(1s,4ar,5s,8ar)-5-formyl-5,8a-dimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]-3-methylpent-2-en-1-yl]oxy}-4-oxobutanoic acid

4-{[(2e)-5-[(1s,4ar,5s,8ar)-5-formyl-5,8a-dimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]-3-methylpent-2-en-1-yl]oxy}-4-oxobutanoic acid

C24H36O5 (404.2563)


   

[(3r,5r)-5-[(2r,6s)-2,6-dimethyl-10-phenyldecyl]-3,5-dimethyl-1,2-dioxolan-3-yl]acetic acid

[(3r,5r)-5-[(2r,6s)-2,6-dimethyl-10-phenyldecyl]-3,5-dimethyl-1,2-dioxolan-3-yl]acetic acid

C25H40O4 (404.2926)


   

8-(acetyloxy)-4a-hydroxy-1-isopropyl-3a,8a-dimethyl-5-methylidene-2h,3h,4h,6h,7h,8h,9h,10h-cyclohexa[f]azulen-9-yl acetate

8-(acetyloxy)-4a-hydroxy-1-isopropyl-3a,8a-dimethyl-5-methylidene-2h,3h,4h,6h,7h,8h,9h,10h-cyclohexa[f]azulen-9-yl acetate

C24H36O5 (404.2563)


   

2-[2-(acetyloxy)ethenyl]-6-methyl-1-oxo-8-(2,6,6-trimethylcyclohex-2-en-1-yl)oct-5-en-2-yl acetate

2-[2-(acetyloxy)ethenyl]-6-methyl-1-oxo-8-(2,6,6-trimethylcyclohex-2-en-1-yl)oct-5-en-2-yl acetate

C24H36O5 (404.2563)


   

{6,14-dihydroxy-5,5,9-trimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-14-yl}methyl 2-methylbut-2-enoate

{6,14-dihydroxy-5,5,9-trimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-14-yl}methyl 2-methylbut-2-enoate

C25H40O4 (404.2926)


   

(1r,2e,6e,8r,10e,12z,14r)-14-(acetyloxy)-8-hydroxy-13-isopropyl-2,6,10-trimethylcyclotetradeca-2,6,10,12-tetraen-1-yl acetate

(1r,2e,6e,8r,10e,12z,14r)-14-(acetyloxy)-8-hydroxy-13-isopropyl-2,6,10-trimethylcyclotetradeca-2,6,10,12-tetraen-1-yl acetate

C24H36O5 (404.2563)


   

2,5-dihydroxy-3-(nonadec-14-en-1-yl)cyclohexa-2,5-diene-1,4-dione

2,5-dihydroxy-3-(nonadec-14-en-1-yl)cyclohexa-2,5-diene-1,4-dione

C25H40O4 (404.2926)


   

1-ethenyl-7,7-dimethoxy-9a,11a-dimethyl-tetradecahydrocyclopenta[a]phenanthren-10-yl acetate

1-ethenyl-7,7-dimethoxy-9a,11a-dimethyl-tetradecahydrocyclopenta[a]phenanthren-10-yl acetate

C25H40O4 (404.2926)


   

[(1r,4s,5s,6r,9s,10s,13r,16s)-16-(acetyloxy)-6-hydroxy-5,9,13-trimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadec-14-en-5-yl]methyl acetate

[(1r,4s,5s,6r,9s,10s,13r,16s)-16-(acetyloxy)-6-hydroxy-5,9,13-trimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadec-14-en-5-yl]methyl acetate

C24H36O5 (404.2563)


   

(1s,4s,6r,9s,10s,13r,14r)-14-hydroxy-14-(hydroxymethyl)-5,5,9-trimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-6-yl (2z)-2-methylbut-2-enoate

(1s,4s,6r,9s,10s,13r,14r)-14-hydroxy-14-(hydroxymethyl)-5,5,9-trimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-6-yl (2z)-2-methylbut-2-enoate

C25H40O4 (404.2926)


   

5-hydroxy-1-(4-hydroxyphenyl)icosan-3-one

5-hydroxy-1-(4-hydroxyphenyl)icosan-3-one

C26H44O3 (404.329)


   

(1s,3z)-5-(acetyloxy)-1-[(1s,4s,6s,10r,12s)-4,12-dimethyl-9-methylidene-5-oxatricyclo[8.2.0.0⁴,⁶]dodecan-12-yl]-4-methylpent-3-en-1-yl acetate

(1s,3z)-5-(acetyloxy)-1-[(1s,4s,6s,10r,12s)-4,12-dimethyl-9-methylidene-5-oxatricyclo[8.2.0.0⁴,⁶]dodecan-12-yl]-4-methylpent-3-en-1-yl acetate

C24H36O5 (404.2563)


   

[4,6-dimethyl-6-(2-methyl-10-phenyldecyl)-1,2-dioxan-3-yl]acetic acid

[4,6-dimethyl-6-(2-methyl-10-phenyldecyl)-1,2-dioxan-3-yl]acetic acid

C25H40O4 (404.2926)


   

5-[(3s,3as,6s,7ar,10r,10ar,10bs)-3,6,7a,10-tetramethyl-1h,2h,3h,4h,5h,6h,8h,9h,10ah,10bh-cyclopenta[d]s-indacen-10-yl]-1,2,4-trihydroxy-2-methylpentan-3-one

5-[(3s,3as,6s,7ar,10r,10ar,10bs)-3,6,7a,10-tetramethyl-1h,2h,3h,4h,5h,6h,8h,9h,10ah,10bh-cyclopenta[d]s-indacen-10-yl]-1,2,4-trihydroxy-2-methylpentan-3-one

C25H40O4 (404.2926)


   

(1r,2e,4s,6s,8e,12e)-4-hydroxy-3,9,13-trimethyl-6-(prop-1-en-2-yl)cyclotetradeca-2,8,12-trien-1-yl (2r,3s)-3-hydroxy-2-methylbutanoate

(1r,2e,4s,6s,8e,12e)-4-hydroxy-3,9,13-trimethyl-6-(prop-1-en-2-yl)cyclotetradeca-2,8,12-trien-1-yl (2r,3s)-3-hydroxy-2-methylbutanoate

C25H40O4 (404.2926)


   

(1r,2s,3r,14s)-2-(acetyloxy)-4-isopropyl-1,7,11-trimethyl-15-oxabicyclo[12.1.0]pentadeca-4,6,10-trien-3-yl acetate

(1r,2s,3r,14s)-2-(acetyloxy)-4-isopropyl-1,7,11-trimethyl-15-oxabicyclo[12.1.0]pentadeca-4,6,10-trien-3-yl acetate

C24H36O5 (404.2563)


   

(1r,2r,3s,4s,5s,7r,8s,11s,17r)-5,8,11-trimethyl-15-methylidene-12-oxo-10,18-dioxatetracyclo[9.7.0.0²,⁷.0³,¹⁷]octadecan-4-yl butanoate

(1r,2r,3s,4s,5s,7r,8s,11s,17r)-5,8,11-trimethyl-15-methylidene-12-oxo-10,18-dioxatetracyclo[9.7.0.0²,⁷.0³,¹⁷]octadecan-4-yl butanoate

C24H36O5 (404.2563)


   

[(1r,4as,4br,7s,10ar)-7-(acetyloxy)-7-isopropyl-1,4a-dimethyl-9-oxo-2,3,4,4b,5,6,10,10a-octahydrophenanthren-1-yl]methyl acetate

[(1r,4as,4br,7s,10ar)-7-(acetyloxy)-7-isopropyl-1,4a-dimethyl-9-oxo-2,3,4,4b,5,6,10,10a-octahydrophenanthren-1-yl]methyl acetate

C24H36O5 (404.2563)


   

5-ethoxy-3-(heptadec-10-en-1-yl)-2-hydroxycyclohexa-2,5-diene-1,4-dione

5-ethoxy-3-(heptadec-10-en-1-yl)-2-hydroxycyclohexa-2,5-diene-1,4-dione

C25H40O4 (404.2926)


   

(1r,5s,8r)-1,3,5-trimethyl-2,8-bis(2-oxoheptyl)-6-oxabicyclo[3.2.1]oct-2-ene-4,7-dione

(1r,5s,8r)-1,3,5-trimethyl-2,8-bis(2-oxoheptyl)-6-oxabicyclo[3.2.1]oct-2-ene-4,7-dione

C24H36O5 (404.2563)


   

4-[(16-hydroxy-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraen-1-yl)oxy]-4-oxobut-2-enoic acid

4-[(16-hydroxy-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraen-1-yl)oxy]-4-oxobut-2-enoic acid

C24H36O5 (404.2563)


   

[2-(acetyloxy)-5-(hydroxymethyl)-5,9-dimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadec-14-en-14-yl]methyl acetate

[2-(acetyloxy)-5-(hydroxymethyl)-5,9-dimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadec-14-en-14-yl]methyl acetate

C24H36O5 (404.2563)


   

(1s,3z)-5-(acetyloxy)-1-[(1r,6s,9s,10s)-6,10-dimethyl-2-methylidene-5-oxobicyclo[7.2.0]undecan-10-yl]-4-methylpent-3-en-1-yl acetate

(1s,3z)-5-(acetyloxy)-1-[(1r,6s,9s,10s)-6,10-dimethyl-2-methylidene-5-oxobicyclo[7.2.0]undecan-10-yl]-4-methylpent-3-en-1-yl acetate

C24H36O5 (404.2563)


   

(1r,4r,8s,9r,10r,12r,13s)-8-(acetyloxy)-13-(hydroxymethyl)-5,5,9-trimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadec-14-en-12-yl acetate

(1r,4r,8s,9r,10r,12r,13s)-8-(acetyloxy)-13-(hydroxymethyl)-5,5,9-trimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadec-14-en-12-yl acetate

C24H36O5 (404.2563)


   

10-hydroxy-5,9,14-trimethyl-6-[(2-methylpropanoyl)oxy]tetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadec-14-ene-5-carboxylic acid

10-hydroxy-5,9,14-trimethyl-6-[(2-methylpropanoyl)oxy]tetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadec-14-ene-5-carboxylic acid

C24H36O5 (404.2563)


   

(1e,3r)-3-(acetyloxy)-3-[(3e)-4-methyl-6-[(1s)-2,6,6-trimethylcyclohex-2-en-1-yl]hex-3-en-1-yl]-4-oxobut-1-en-1-yl acetate

(1e,3r)-3-(acetyloxy)-3-[(3e)-4-methyl-6-[(1s)-2,6,6-trimethylcyclohex-2-en-1-yl]hex-3-en-1-yl]-4-oxobut-1-en-1-yl acetate

C24H36O5 (404.2563)


   

4-hydroxy-2-methyl-3,6-dioxo-5-[(10z)-pentadec-10-en-1-yl]cyclohexa-1,4-dien-1-yl acetate

4-hydroxy-2-methyl-3,6-dioxo-5-[(10z)-pentadec-10-en-1-yl]cyclohexa-1,4-dien-1-yl acetate

C24H36O5 (404.2563)


   

8-(acetyloxy)-4a-hydroxy-1-isopropyl-3a,8a-dimethyl-5-methylidene-2h,3h,4h,6h,7h,8h,9h,10h-cyclohexa[f]azulen-10-yl acetate

8-(acetyloxy)-4a-hydroxy-1-isopropyl-3a,8a-dimethyl-5-methylidene-2h,3h,4h,6h,7h,8h,9h,10h-cyclohexa[f]azulen-10-yl acetate

C24H36O5 (404.2563)


   

[(1e,3s,4r,7e,10e,12r)-3-(acetyloxy)-12-hydroxy-7,11-dimethyl-4-(prop-1-en-2-yl)cyclotetradeca-1,7,10-trien-1-yl]methyl acetate

[(1e,3s,4r,7e,10e,12r)-3-(acetyloxy)-12-hydroxy-7,11-dimethyl-4-(prop-1-en-2-yl)cyclotetradeca-1,7,10-trien-1-yl]methyl acetate

C24H36O5 (404.2563)


   

7-hydroxy-3-(2-hydroxypropyl)-7-methyl-8-(2-oxoundecyl)-8h-isochromen-6-one

7-hydroxy-3-(2-hydroxypropyl)-7-methyl-8-(2-oxoundecyl)-8h-isochromen-6-one

C24H36O5 (404.2563)


   

ethyl 4-(2,4b,8,8,10a-pentamethyl-3-oxo-decahydrophenanthren-1-yl)-2-methylbutanoate

ethyl 4-(2,4b,8,8,10a-pentamethyl-3-oxo-decahydrophenanthren-1-yl)-2-methylbutanoate

C26H44O3 (404.329)


   

[5-(2,6-dimethyl-10-phenyldecyl)-3,5-dimethyl-1,2-dioxolan-3-yl]acetic acid

[5-(2,6-dimethyl-10-phenyldecyl)-3,5-dimethyl-1,2-dioxolan-3-yl]acetic acid

C25H40O4 (404.2926)


   

ethyl (2r)-3-[(1s,2s,4ar,4bs,8as,10ar)-2-formyl-2,4b,8,8,10a-pentamethyl-decahydrophenanthren-1-yl]-2-methylpropanoate

ethyl (2r)-3-[(1s,2s,4ar,4bs,8as,10ar)-2-formyl-2,4b,8,8,10a-pentamethyl-decahydrophenanthren-1-yl]-2-methylpropanoate

C26H44O3 (404.329)


   

(6bs,8as,12ar,12bs,14ar)-3-hydroxy-4,6b,8a,11,12b,14a-hexamethyl-8,9,12,12a,13,14-hexahydro-7h-picen-2-one

(6bs,8as,12ar,12bs,14ar)-3-hydroxy-4,6b,8a,11,12b,14a-hexamethyl-8,9,12,12a,13,14-hexahydro-7h-picen-2-one

C28H36O2 (404.2715)


   

(2s)-1-[(1s)-1-{[(5s,6r,7s,10r)-7-isopropyl-2,10-dimethylspiro[4.5]dec-1-en-6-yl]-c-hydroxycarbonimidoyl}ethyl]-5-oxopyrrolidine-2-carboxylic acid

(2s)-1-[(1s)-1-{[(5s,6r,7s,10r)-7-isopropyl-2,10-dimethylspiro[4.5]dec-1-en-6-yl]-c-hydroxycarbonimidoyl}ethyl]-5-oxopyrrolidine-2-carboxylic acid

C23H36N2O4 (404.2675)


   

(4s)-5-[(3s,3as,6s,7ar,10r,10ar,10bs)-3,6,7a,10-tetramethyl-1h,2h,3h,4h,5h,6h,8h,9h,10ah,10bh-cyclopenta[d]s-indacen-10-yl]-1,2,4-trihydroxy-2-methylpentan-3-one

(4s)-5-[(3s,3as,6s,7ar,10r,10ar,10bs)-3,6,7a,10-tetramethyl-1h,2h,3h,4h,5h,6h,8h,9h,10ah,10bh-cyclopenta[d]s-indacen-10-yl]-1,2,4-trihydroxy-2-methylpentan-3-one

C25H40O4 (404.2926)


   

(3r,7s,10r,11r)-10-hydroxy-3,7,11-trimethylhexadecyl benzoate

(3r,7s,10r,11r)-10-hydroxy-3,7,11-trimethylhexadecyl benzoate

C26H44O3 (404.329)


   

1-[1-({7-isopropyl-2,10-dimethylspiro[4.5]dec-1-en-6-yl}-c-hydroxycarbonimidoyl)ethyl]-5-oxopyrrolidine-2-carboxylic acid

1-[1-({7-isopropyl-2,10-dimethylspiro[4.5]dec-1-en-6-yl}-c-hydroxycarbonimidoyl)ethyl]-5-oxopyrrolidine-2-carboxylic acid

C23H36N2O4 (404.2675)


   

(4ar,4br,7s,9s,10r,10as)-7,10-dihydroxy-7-isopropyl-1,1,4a-trimethyl-3,4,4b,5,6,9,10,10a-octahydro-2h-phenanthren-9-yl 3-methylbut-2-enoate

(4ar,4br,7s,9s,10r,10as)-7,10-dihydroxy-7-isopropyl-1,1,4a-trimethyl-3,4,4b,5,6,9,10,10a-octahydro-2h-phenanthren-9-yl 3-methylbut-2-enoate

C25H40O4 (404.2926)


   

2-ethenyl-3,10a-dihydroxy-2,4b,8,8-tetramethyl-decahydrophenanthren-4-yl 3-methylbut-2-enoate

2-ethenyl-3,10a-dihydroxy-2,4b,8,8-tetramethyl-decahydrophenanthren-4-yl 3-methylbut-2-enoate

C25H40O4 (404.2926)


   

1-[9-(2,2-dimethyl-6-methylidenecyclohexyl)-3,7-dimethylnona-2,6-dien-1-yl] 3-ethyl propanedioate

1-[9-(2,2-dimethyl-6-methylidenecyclohexyl)-3,7-dimethylnona-2,6-dien-1-yl] 3-ethyl propanedioate

C25H40O4 (404.2926)


   

4-{4-[2-(2,5,5,8a-tetramethyl-3,4,4a,6,7,8-hexahydronaphthalen-1-yl)ethyl]-1,5-dihydroxypent-3-en-1-yl}oxolan-2-one

4-{4-[2-(2,5,5,8a-tetramethyl-3,4,4a,6,7,8-hexahydronaphthalen-1-yl)ethyl]-1,5-dihydroxypent-3-en-1-yl}oxolan-2-one

C25H40O4 (404.2926)


   

(5r)-5-hydroxy-1-(4-hydroxyphenyl)icosan-3-one

(5r)-5-hydroxy-1-(4-hydroxyphenyl)icosan-3-one

C26H44O3 (404.329)


   

[(3s,4s,6r)-4,6-dimethyl-6-[(2r)-2-methyl-10-phenyldecyl]-1,2-dioxan-3-yl]acetic acid

[(3s,4s,6r)-4,6-dimethyl-6-[(2r)-2-methyl-10-phenyldecyl]-1,2-dioxan-3-yl]acetic acid

C25H40O4 (404.2926)


   

2,6,6-trimethyl-3,3-bis({2,6,6-trimethylbicyclo[3.1.1]hept-1-en-3-yl})bicyclo[3.1.1]hept-1-ene

2,6,6-trimethyl-3,3-bis({2,6,6-trimethylbicyclo[3.1.1]hept-1-en-3-yl})bicyclo[3.1.1]hept-1-ene

C30H44 (404.3443)


   

(4e,6e,8e,10e,12e,14e,18e)-2,6,10,15,19,23-hexamethyltetracosa-2,4,6,8,10,12,14,18,22-nonaene

(4e,6e,8e,10e,12e,14e,18e)-2,6,10,15,19,23-hexamethyltetracosa-2,4,6,8,10,12,14,18,22-nonaene

C30H44 (404.3443)


   

(2s,3s,4s,4as,4bs,8as,10ar)-2-ethenyl-3,10a-dihydroxy-2,4b,8,8-tetramethyl-decahydrophenanthren-4-yl 3-methylbut-2-enoate

(2s,3s,4s,4as,4bs,8as,10ar)-2-ethenyl-3,10a-dihydroxy-2,4b,8,8-tetramethyl-decahydrophenanthren-4-yl 3-methylbut-2-enoate

C25H40O4 (404.2926)


   

(2s)-1-[(1r)-1-{[(5s,6r,7s,10r)-7-isopropyl-2,10-dimethylspiro[4.5]dec-1-en-6-yl]-c-hydroxycarbonimidoyl}ethyl]-5-oxopyrrolidine-2-carboxylic acid

(2s)-1-[(1r)-1-{[(5s,6r,7s,10r)-7-isopropyl-2,10-dimethylspiro[4.5]dec-1-en-6-yl]-c-hydroxycarbonimidoyl}ethyl]-5-oxopyrrolidine-2-carboxylic acid

C23H36N2O4 (404.2675)


   

methyl (2r)-2-[(3r,6r)-6-{2-[(4ar,8as)-1,1,3,6-tetramethyl-4a,7,8,8a-tetrahydro-4h-naphthalen-2-yl]ethyl}-6-methyl-1,2-dioxan-3-yl]propanoate

methyl (2r)-2-[(3r,6r)-6-{2-[(4ar,8as)-1,1,3,6-tetramethyl-4a,7,8,8a-tetrahydro-4h-naphthalen-2-yl]ethyl}-6-methyl-1,2-dioxan-3-yl]propanoate

C25H40O4 (404.2926)


   

(6bs,8as,12as,12bs,14ar)-3-hydroxy-4,6b,8a,11,12b,14a-hexamethyl-8,9,12,12a,13,14-hexahydro-7h-picen-2-one

(6bs,8as,12as,12bs,14ar)-3-hydroxy-4,6b,8a,11,12b,14a-hexamethyl-8,9,12,12a,13,14-hexahydro-7h-picen-2-one

C28H36O2 (404.2715)


   

4,4'-diapo-zeta-carotene

4,4'-diapo-zeta-carotene

C30H44 (404.3443)


   

(1r,3as,3bs,5r,5ar,7s,9ar,9bs,11ar)-9a,11a-dimethyl-1-[(2r,3e)-5-methylhex-3-en-2-yl]-tetradecahydrocyclopenta[a]phenanthrene-5,5a,7-triol

(1r,3as,3bs,5r,5ar,7s,9ar,9bs,11ar)-9a,11a-dimethyl-1-[(2r,3e)-5-methylhex-3-en-2-yl]-tetradecahydrocyclopenta[a]phenanthrene-5,5a,7-triol

C26H44O3 (404.329)


   

7,10-dihydroxy-7-isopropyl-1,1,4a-trimethyl-3,4,4b,5,6,9,10,10a-octahydro-2h-phenanthren-9-yl 3-methylbut-2-enoate

7,10-dihydroxy-7-isopropyl-1,1,4a-trimethyl-3,4,4b,5,6,9,10,10a-octahydro-2h-phenanthren-9-yl 3-methylbut-2-enoate

C25H40O4 (404.2926)


   

methyl (1s,2s,3s,6r,7s,11r,12r)-2-(7-phenylheptyl)tetracyclo[8.2.1.0³,¹².0⁶,¹¹]trideca-4,8-diene-7-carboxylate

methyl (1s,2s,3s,6r,7s,11r,12r)-2-(7-phenylheptyl)tetracyclo[8.2.1.0³,¹².0⁶,¹¹]trideca-4,8-diene-7-carboxylate

C28H36O2 (404.2715)


   

(2s,4s)-5-[(3s,3as,6s,7ar,10r,10ar,10bs)-3,6,7a,10-tetramethyl-1h,2h,3h,4h,5h,6h,8h,9h,10ah,10bh-cyclopenta[d]s-indacen-10-yl]-1,2,4-trihydroxy-2-methylpentan-3-one

(2s,4s)-5-[(3s,3as,6s,7ar,10r,10ar,10bs)-3,6,7a,10-tetramethyl-1h,2h,3h,4h,5h,6h,8h,9h,10ah,10bh-cyclopenta[d]s-indacen-10-yl]-1,2,4-trihydroxy-2-methylpentan-3-one

C25H40O4 (404.2926)


   

5-(6-hydroxy-2,5,5,8a-tetramethyl-1,4,4a,6,7,8-hexahydronaphthalen-1-yl)-3-methylpent-2-en-1-yl 3-methylpentanoate

5-(6-hydroxy-2,5,5,8a-tetramethyl-1,4,4a,6,7,8-hexahydronaphthalen-1-yl)-3-methylpent-2-en-1-yl 3-methylpentanoate

C26H44O3 (404.329)


   

3-hydroxy-2-methyl-5-nonadecylcyclohexa-2,5-diene-1,4-dione

3-hydroxy-2-methyl-5-nonadecylcyclohexa-2,5-diene-1,4-dione

C26H44O3 (404.329)


   

methyl 2,4-dimethoxy-6-(pentadec-8-en-1-yl)benzoate

methyl 2,4-dimethoxy-6-(pentadec-8-en-1-yl)benzoate

C25H40O4 (404.2926)


   

5-ethoxy-3-[(10z)-heptadec-10-en-1-yl]-2-hydroxycyclohexa-2,5-diene-1,4-dione

5-ethoxy-3-[(10z)-heptadec-10-en-1-yl]-2-hydroxycyclohexa-2,5-diene-1,4-dione

C25H40O4 (404.2926)


   

3-hydroxy-4,6b,8a,11,12b,14a-hexamethyl-8,9,12,12a,13,14-hexahydro-7h-picen-2-one

3-hydroxy-4,6b,8a,11,12b,14a-hexamethyl-8,9,12,12a,13,14-hexahydro-7h-picen-2-one

C28H36O2 (404.2715)


   

(2e)-5-[(1r,4as,6s,8as)-6-hydroxy-2,5,5,8a-tetramethyl-1,4,4a,6,7,8-hexahydronaphthalen-1-yl]-3-methylpent-2-en-1-yl (3s)-3-methylpentanoate

(2e)-5-[(1r,4as,6s,8as)-6-hydroxy-2,5,5,8a-tetramethyl-1,4,4a,6,7,8-hexahydronaphthalen-1-yl]-3-methylpent-2-en-1-yl (3s)-3-methylpentanoate

C26H44O3 (404.329)


   

pentadecyl (2e)-3-(2-hydroxy-4-methoxyphenyl)prop-2-enoate

pentadecyl (2e)-3-(2-hydroxy-4-methoxyphenyl)prop-2-enoate

C25H40O4 (404.2926)


   

14-oxo-7,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadecan-4-yl 3-hydroxyoct-5-enoate

14-oxo-7,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadecan-4-yl 3-hydroxyoct-5-enoate

C23H36N2O4 (404.2675)


   

(3r,4s)-1,4-dimethyl-4-[(1e,3e)-4-[(1r)-4-methylcyclohex-3-en-1-yl]penta-1,3-dien-1-yl]-3-[(1e)-2-[(1r)-4-methylcyclohex-3-en-1-yl]prop-1-en-1-yl]cyclohex-1-ene

(3r,4s)-1,4-dimethyl-4-[(1e,3e)-4-[(1r)-4-methylcyclohex-3-en-1-yl]penta-1,3-dien-1-yl]-3-[(1e)-2-[(1r)-4-methylcyclohex-3-en-1-yl]prop-1-en-1-yl]cyclohex-1-ene

C30H44 (404.3443)


   

(2s,3s,4s,4as,4bs,8as,10ar)-2-ethenyl-3,10a-dihydroxy-2,4b,8,8-tetramethyl-decahydrophenanthren-4-yl (2e)-2-methylbut-2-enoate

(2s,3s,4s,4as,4bs,8as,10ar)-2-ethenyl-3,10a-dihydroxy-2,4b,8,8-tetramethyl-decahydrophenanthren-4-yl (2e)-2-methylbut-2-enoate

C25H40O4 (404.2926)


   

5,9-dimethyl-14-{[(3-methylbutanoyl)oxy]methyl}tetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylic acid

5,9-dimethyl-14-{[(3-methylbutanoyl)oxy]methyl}tetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylic acid

C25H40O4 (404.2926)


   

5-{3,6,7a,10-tetramethyl-1h,2h,3h,4h,5h,6h,8h,9h,10ah,10bh-cyclopenta[d]s-indacen-10-yl}-1,2,4-trihydroxy-2-methylpentan-3-one

5-{3,6,7a,10-tetramethyl-1h,2h,3h,4h,5h,6h,8h,9h,10ah,10bh-cyclopenta[d]s-indacen-10-yl}-1,2,4-trihydroxy-2-methylpentan-3-one

C25H40O4 (404.2926)


   

(4r)-4-[(1r,3z)-4-{2-[(4as,8as)-2,5,5,8a-tetramethyl-3,4,4a,6,7,8-hexahydronaphthalen-1-yl]ethyl}-1,5-dihydroxypent-3-en-1-yl]oxolan-2-one

(4r)-4-[(1r,3z)-4-{2-[(4as,8as)-2,5,5,8a-tetramethyl-3,4,4a,6,7,8-hexahydronaphthalen-1-yl]ethyl}-1,5-dihydroxypent-3-en-1-yl]oxolan-2-one

C25H40O4 (404.2926)


   

ethyl 3-(2-formyl-2,4b,8,8,10a-pentamethyl-decahydrophenanthren-1-yl)-2-methylpropanoate

ethyl 3-(2-formyl-2,4b,8,8,10a-pentamethyl-decahydrophenanthren-1-yl)-2-methylpropanoate

C26H44O3 (404.329)


   

(2r,4ar,4br,8as,9r,10s)-2,10-dihydroxy-2-isopropyl-4b,8,8-trimethyl-4,4a,5,6,7,8a,9,10-octahydro-3h-phenanthren-9-yl 3-methylbut-2-enoate

(2r,4ar,4br,8as,9r,10s)-2,10-dihydroxy-2-isopropyl-4b,8,8-trimethyl-4,4a,5,6,7,8a,9,10-octahydro-3h-phenanthren-9-yl 3-methylbut-2-enoate

C25H40O4 (404.2926)


   

2,3-dihydroxy-3,4a,8,8-tetramethyl-4-(3-methylpenta-2,4-dien-1-yl)-hexahydro-1h-naphthalen-1-yl 2-methylbut-2-enoate

2,3-dihydroxy-3,4a,8,8-tetramethyl-4-(3-methylpenta-2,4-dien-1-yl)-hexahydro-1h-naphthalen-1-yl 2-methylbut-2-enoate

C25H40O4 (404.2926)


   

4-hydroxy-3,9,13-trimethyl-6-(prop-1-en-2-yl)cyclotetradeca-2,8,12-trien-1-yl 3-hydroxy-2-methylbutanoate

4-hydroxy-3,9,13-trimethyl-6-(prop-1-en-2-yl)cyclotetradeca-2,8,12-trien-1-yl 3-hydroxy-2-methylbutanoate

C25H40O4 (404.2926)


   

(1s,2r,4as,5r,8as)-5-[(3e)-5-hydroxy-3-methylpent-3-en-1-yl]-1-(hydroxymethyl)-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalen-2-yl (2z)-2-methylbut-2-enoate

(1s,2r,4as,5r,8as)-5-[(3e)-5-hydroxy-3-methylpent-3-en-1-yl]-1-(hydroxymethyl)-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalen-2-yl (2z)-2-methylbut-2-enoate

C25H40O4 (404.2926)


   

(4r,5r)-5-[(2z)-4-hydroxy-3-[(3e)-4-methyl-6-(2,6,6-trimethylcyclohex-1-en-1-yl)hex-3-en-1-yl]but-2-en-1-yl]-4-(hydroxymethyl)oxolan-2-one

(4r,5r)-5-[(2z)-4-hydroxy-3-[(3e)-4-methyl-6-(2,6,6-trimethylcyclohex-1-en-1-yl)hex-3-en-1-yl]but-2-en-1-yl]-4-(hydroxymethyl)oxolan-2-one

C25H40O4 (404.2926)


   

(2r)-2,3-dihydroxypropyl (8r,9e,11s,12s)-8,11,12-trihydroxyoctadec-9-enoate

(2r)-2,3-dihydroxypropyl (8r,9e,11s,12s)-8,11,12-trihydroxyoctadec-9-enoate

C21H40O7 (404.2774)


   

methyl 2,4-dimethoxy-6-[(8z)-pentadec-8-en-1-yl]benzoate

methyl 2,4-dimethoxy-6-[(8z)-pentadec-8-en-1-yl]benzoate

C25H40O4 (404.2926)


   

1-(2e,6e)-9-[(1s)-2,2-dimethyl-6-methylidenecyclohexyl]-3,7-dimethylnona-2,6-dien-1-yl 3-ethyl propanedioate

1-(2e,6e)-9-[(1s)-2,2-dimethyl-6-methylidenecyclohexyl]-3,7-dimethylnona-2,6-dien-1-yl 3-ethyl propanedioate

C25H40O4 (404.2926)


   

(1s,2s,5s,8s,9s,10s,11s,12r,13s,14s,16r,17s)-16-(2-hydroxypropan-2-yl)-5,9,10,13-tetramethylhexacyclo[9.7.0.0²,⁶.0²,⁹.0¹²,¹⁷.0¹³,¹⁷]octadecane-5,8,14-triol

(1s,2s,5s,8s,9s,10s,11s,12r,13s,14s,16r,17s)-16-(2-hydroxypropan-2-yl)-5,9,10,13-tetramethylhexacyclo[9.7.0.0²,⁶.0²,⁹.0¹²,¹⁷.0¹³,¹⁷]octadecane-5,8,14-triol

C25H40O4 (404.2926)


   

2-ethenyl-3,10a-dihydroxy-2,4b,8,8-tetramethyl-decahydrophenanthren-4-yl 2-methylbut-2-enoate

2-ethenyl-3,10a-dihydroxy-2,4b,8,8-tetramethyl-decahydrophenanthren-4-yl 2-methylbut-2-enoate

C25H40O4 (404.2926)


   

(2z)-5-[(1r,4ar,8ar)-5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]-3-({[(2r)-2-methylbutanoyl]oxy}methyl)pent-2-enoic acid

(2z)-5-[(1r,4ar,8ar)-5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]-3-({[(2r)-2-methylbutanoyl]oxy}methyl)pent-2-enoic acid

C25H40O4 (404.2926)


   

3-hydroxy-5-(5-hydroxy-3-methylpent-3-en-1-yl)-1,1,4a,6-tetramethyl-2,3,4,5,8,8a-hexahydronaphthalen-2-yl 2-methylbut-2-enoate

3-hydroxy-5-(5-hydroxy-3-methylpent-3-en-1-yl)-1,1,4a,6-tetramethyl-2,3,4,5,8,8a-hexahydronaphthalen-2-yl 2-methylbut-2-enoate

C25H40O4 (404.2926)


   

ethyl (2r)-4-[(1s,2s,4ar,4br,8ar,10ar)-2,4b,8,8,10a-pentamethyl-3-oxo-decahydrophenanthren-1-yl]-2-methylbutanoate

ethyl (2r)-4-[(1s,2s,4ar,4br,8ar,10ar)-2,4b,8,8,10a-pentamethyl-3-oxo-decahydrophenanthren-1-yl]-2-methylbutanoate

C26H44O3 (404.329)


   

2,10-dihydroxy-2-isopropyl-4b,8,8-trimethyl-4,4a,5,6,7,8a,9,10-octahydro-3h-phenanthren-9-yl 3-methylbut-2-enoate

2,10-dihydroxy-2-isopropyl-4b,8,8-trimethyl-4,4a,5,6,7,8a,9,10-octahydro-3h-phenanthren-9-yl 3-methylbut-2-enoate

C25H40O4 (404.2926)


   

[(1r,2s,4r,9r,10s,13r,14r)-2,14-dihydroxy-5,5,9-trimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-14-yl]methyl 3-methylbut-2-enoate

[(1r,2s,4r,9r,10s,13r,14r)-2,14-dihydroxy-5,5,9-trimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-14-yl]methyl 3-methylbut-2-enoate

C25H40O4 (404.2926)


   

(2s,3s,4as,5r,8as)-3-hydroxy-5-[(3e)-5-hydroxy-3-methylpent-3-en-1-yl]-1,1,4a,6-tetramethyl-2,3,4,5,8,8a-hexahydronaphthalen-2-yl (2z)-2-methylbut-2-enoate

(2s,3s,4as,5r,8as)-3-hydroxy-5-[(3e)-5-hydroxy-3-methylpent-3-en-1-yl]-1,1,4a,6-tetramethyl-2,3,4,5,8,8a-hexahydronaphthalen-2-yl (2z)-2-methylbut-2-enoate

C25H40O4 (404.2926)


   

(1r,5bs,11as,13r,13as,13bs)-5b-(hydroxymethyl)-8,8,11a,13a-tetramethyl-1h,3h,5h,5ah,6h,7h,7ah,9h,10h,11h,11bh,12h,13h,13bh-chryseno[1,2-c]furan-1,13-diol

(1r,5bs,11as,13r,13as,13bs)-5b-(hydroxymethyl)-8,8,11a,13a-tetramethyl-1h,3h,5h,5ah,6h,7h,7ah,9h,10h,11h,11bh,12h,13h,13bh-chryseno[1,2-c]furan-1,13-diol

C25H40O4 (404.2926)


   

(1r,2s,3s,4r,4as,8as)-2,3-dihydroxy-3,4a,8,8-tetramethyl-4-[(2e)-3-methylpenta-2,4-dien-1-yl]-hexahydro-1h-naphthalen-1-yl (2z)-2-methylbut-2-enoate

(1r,2s,3s,4r,4as,8as)-2,3-dihydroxy-3,4a,8,8-tetramethyl-4-[(2e)-3-methylpenta-2,4-dien-1-yl]-hexahydro-1h-naphthalen-1-yl (2z)-2-methylbut-2-enoate

C25H40O4 (404.2926)


   

(1s,2s,4s,9s,10r)-14-oxo-7,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadecan-4-yl (3s,5z)-3-hydroxyoct-5-enoate

(1s,2s,4s,9s,10r)-14-oxo-7,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadecan-4-yl (3s,5z)-3-hydroxyoct-5-enoate

C23H36N2O4 (404.2675)


   

5-(2,5,8a-trimethyl-5-{[(2-methylbut-2-enoyl)oxy]methyl}-1,4,4a,6,7,8-hexahydronaphthalen-1-yl)-3-methylpentanoic acid

5-(2,5,8a-trimethyl-5-{[(2-methylbut-2-enoyl)oxy]methyl}-1,4,4a,6,7,8-hexahydronaphthalen-1-yl)-3-methylpentanoic acid

C25H40O4 (404.2926)


   

methyl (1s,2s,3r,6r,7r,10s,11s,12s)-2-(7-phenylheptyl)tetracyclo[8.2.1.0³,¹².0⁶,¹¹]trideca-4,8-diene-7-carboxylate

methyl (1s,2s,3r,6r,7r,10s,11s,12s)-2-(7-phenylheptyl)tetracyclo[8.2.1.0³,¹².0⁶,¹¹]trideca-4,8-diene-7-carboxylate

C28H36O2 (404.2715)


   

14-hydroxy-14-(hydroxymethyl)-5,5,9-trimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-6-yl 2-methylbut-2-enoate

14-hydroxy-14-(hydroxymethyl)-5,5,9-trimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-6-yl 2-methylbut-2-enoate

C25H40O4 (404.2926)